IDEX (IEX) 10-K 13 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Feb. 10, 2014	Jun. 28, 2013
Document Documentand Entity Information [Abstract]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Trading Symbol	'IEX	'	'
Entity Registrant Name	'IDEX CORP /DE/	'	'
Entity Central Index Key	'0000832101	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	80,889,147	'
Entity Public Float	'	'	$4,383,366,044

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$439,629	$318,864
Receivables - net	253,226	256,095
Inventories	230,967	234,950
Other current assets	67,131	71,956
Total current assets	990,953	881,865
Property, plant and equipment - net	213,488	219,161
Goodwill	1,349,456	1,321,727
Intangible assets - net	311,227	341,372
Other noncurrent assets	22,453	21,265
Total assets	2,887,577	2,785,390
Current liabilities	'	'
Trade accounts payable	133,312	117,341
Accrued expenses	150,751	150,176
Short-term borrowings	1,871	7,335
Dividends payable	18,675	16,575
Total current liabilities	304,609	291,427
Long-term borrowings	772,005	779,241
Deferred income taxes	144,908	121,349
Other noncurrent liabilities	93,066	128,375
Total liabilities	1,314,588	1,320,392
Commitments and contingencies (Note 8)	'	'
Preferred stock:	'	'
Authorized: 5,000,000 shares, $.01 per share par value; Issued: none	'	'
Common stock:	'	'
Authorized: 150,000,000 shares, $.01 per share par value; Issued: 89,154,190 shares at December 31, 2013 and 87,732,405 shares at December 31, 2012	892	877
Additional paid-in capital	607,766	550,682
Retained earnings	1,293,740	1,113,541
Treasury stock at cost: 7,958,510 shares at December 31, 2013 and 5,005,518 shares at December 31, 2012	-326,104	-156,699
Accumulated other comprehensive loss	-3,305	-43,403
Total shareholders' equity	1,572,989	1,464,998
Total liabilities and shareholders' equity	$2,887,577	$2,785,390

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]	'	'
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares issued	0	0
Common stock, shares authorized	150,000,000	150,000,000
Common stock, par value	$0.01	$0.01
Common stock, shares issued	89,154,190	87,732,405
Treasury stock, shares	7,958,510	5,005,518

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Income Statement [Abstract]	'		'		'
Net sales	$2,024,130		$1,954,258		$1,838,451
Cost of sales	1,150,766		1,150,558		1,099,778
Gross profit	873,364		803,700		738,673
Selling, general and administrative expenses	477,851		444,490		421,703
Asset impairments	0		198,519		0
Restructuring expenses	0		32,473		12,314
Operating income	395,513	[1]	128,218	[1]	304,656	[1]
Other income (expense) - net	-178		236		-1,443
Interest expense	42,206		42,250		29,332
Income before income taxes	353,129		86,204		273,881
Provision for income taxes	97,914		48,574		80,024
Net income	$255,215		$37,630		$193,857
Earnings per common share:	'		'		'
Basic earnings per common share	$3.11		$0.45		$2.34
Diluted earnings per common share	$3.09		$0.45		$2.32
Share data:	'		'		'
Basic weighted average common shares outstanding	81,517		82,689		82,145
Diluted weighted average common shares outstanding	82,489		83,641		83,543
[1]	(1)Segment operating income excludes net unallocated corporate operating expenses.

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement of Comprehensive Income [Abstract]	'	'	'
Net income	$255,215	$37,630	$193,857
Other comprehensive income (loss)	'	'	'
Gains (losses) and reclassification adjustments for derivatives, net of tax	4,738	4,780	-20,254
Pension and other postretirement adjustments, net of tax	21,788	-7,159	-8,398
Cumulative translation adjustment	13,572	14,445	-14,108
Comprehensive income	$295,313	$49,696	$151,097

CONSOLIDATED_STATEMENTS_OF_SHA

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (USD $)	Total	Common Stock Including Additional Paid in Capital	Retained Earnings	Cumulative Foreign Currency Translation Adjustments	Retirement Benefits Adjustments	Cumulative Unrealized Gain (Loss) on Derivatives	Treasury Stock
In Thousands
Balance at Dec. 31, 2010	$1,375,660	$442,117	$1,005,040	$38,302	($30,088)	($20,923)	($58,788)
Net income	193,857	'	193,857	'	'	'	'
Cumulative translation adjustment	-14,108	'	'	-14,108	'	'	'
Net change in retirement obligations, net of tax	-8,398	'	'	'	-8,398	'	'
Net change on derivatives designated as cash flow hedges, net of tax	-20,254	'	'	'	'	-20,254	'
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans, net of tax	37,621	37,621	'	'	'	'	'
Share-based compensation	11,250	11,250	'	'	'	'	'
Unvested shares surrendered for tax withholding	-6,008	'	'	'	'	'	-6,008
Cash dividends declared	-56,485	'	-56,485	'	'	'	'
Balance at Dec. 31, 2011	1,513,135	490,988	1,142,412	24,194	-38,486	-41,177	-64,796
Net income	37,630	'	37,630	'	'	'	'
Cumulative translation adjustment	14,445	'	'	14,445	'	'	'
Net change in retirement obligations, net of tax	-7,159	'	'	'	-7,159	'	'
Net change on derivatives designated as cash flow hedges, net of tax	4,780	'	'	'	'	4,780	'
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans, net of tax	49,721	49,721	'	'	'	'	'
Repurchase of 2,182,946 shares of common stock	-89,563	'	'	'	'	'	-89,563
Share-based compensation	10,850	10,850	'	'	'	'	'
Unvested shares surrendered for tax withholding	-2,340	'	'	'	'	'	-2,340
Cash dividends declared	-66,501	'	-66,501	'	'	'	'
Balance at Dec. 31, 2012	1,464,998	551,559	1,113,541	38,639	-45,645	-36,397	-156,699
Net income	255,215	'	255,215	'	'	'	'
Cumulative translation adjustment	13,572	'	'	13,572	'	'	'
Net change in retirement obligations, net of tax	21,788	'	'	'	21,788	'	'
Net change on derivatives designated as cash flow hedges, net of tax	4,738	'	'	'	'	4,738	'
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans, net of tax	43,749	43,749	'	'	'	'	'
Repurchase of 2,182,946 shares of common stock	-167,503	'	'	'	'	'	-167,503
Share-based compensation	13,350	13,350	'	'	'	'	'
Unvested shares surrendered for tax withholding	-1,902	'	'	'	'	'	-1,902
Cash dividends declared	-75,016	'	-75,016	'	'	'	'
Balance at Dec. 31, 2013	$1,572,989	$608,658	$1,293,740	$52,211	($23,857)	($31,659)	($326,104)

CONSOLIDATED_STATEMENTS_OF_SHA1

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement of Stockholders' Equity [Abstract]	'	'	'
Tax benefit (expense) on change in retirement obligations, tax	$1,385	$1,647	$4,222
Tax benefit from change on derivatives designated as cash flow hedges, tax	2,692	2,791	12,500
Repurchase of common stock, shares	2,916,280	2,182,946	'
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans, shares	1,471,568	1,826,977	1,596,145
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans, tax	$4,514	$4,865	$4,150
Cash dividends declared, per common share outstanding	$0.89	$0.80	$0.68

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities	'	'	'
Net income	$255,215	$37,630	$193,857
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Gain on sale of fixed assets	-96	0	-2,831
Asset impairments	2,747	198,519	0
Depreciation and amortization	35,007	36,827	36,882
Amortization of intangible assets	44,327	41,485	35,504
Amortization of debt issuance expenses	1,703	1,685	1,263
Share-based compensation expense	16,993	13,102	12,076
Deferred income taxes	-3,156	-37,229	-3,576
Excess tax benefit from share-based compensation	-8,560	-4,474	-5,298
Non-cash interest expense associated with forward starting swaps	7,430	7,637	3,570
Forward starting interest rate contract settlement	0	0	-38,707
Changes in (net of the effect from acquisitions):	'	'	'
Receivables	6,195	12,747	-16,488
Inventories	9,088	23,799	-607
Other current assets	6,562	-12,127	877
Trade accounts payable	15,460	-1,376	-8,645
Accrued expenses	11,790	9,944	7,411
Other - net	817	-1,989	1,953
Net cash flows provided by operating activities	401,522	326,180	217,241
Cash flows from investing activities	'	'	'
Purchases of property, plant and equipment	-31,536	-35,807	-35,175
Acquisition of businesses, net of cash acquired	-36,849	-68,930	-443,634
Proceeds from fixed asset disposals	567	0	12,651
Other - net	-344	-529	-3,379
Net cash flows used in investing activities	-68,162	-105,266	-469,537
Cash flows from financing activities	'	'	'
Borrowings under revolving facilities and credit facilities for acquisitions	34,648	35,000	365,000
Borrowings under revolving facilities	38,453	94,479	471,222
Proceeds from issuance of Senior Notes	0	0	349,125
Payments under revolving facilities, credit facilities and term loan	-89,478	-158,825	-906,115
Debt issuance costs	0	0	-5,451
Dividends paid	-72,905	-64,087	-54,613
Cash received from options exercised	35,306	45,771	33,064
Excess tax benefit from share-based compensation	8,560	4,474	5,298
Purchase of common stock	-167,503	-89,563	0
Unvested shares surrendered for tax withholding	-1,902	-2,340	-6,008
Other	-4,224	-1,394	1,890
Net cash flows (used in) provided by financing activities	-219,045	-136,485	253,412
Effect of exchange rate changes on cash and cash equivalents	6,450	4,176	-5,993
Net increase (decrease) in cash	120,765	88,605	-4,877
Cash and cash equivalents at beginning of year	318,864	230,259	235,136
Cash and cash equivalents at end of period	439,629	318,864	230,259
Cash paid for:	'	'	'
Interest	33,432	32,639	27,749
Income taxes	73,657	87,603	66,087
Significant non-cash activities:	'	'	'
Contingent consideration for acquisition	0	8,370	3,000
Debt acquired with acquisition of business	$0	$4,680	$1,400

CONSOLIDATED_STATEMENTS_OF_CAS1

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (4.2% Senior Notes)	Dec. 31, 2013	Dec. 31, 2011
4.2% Senior Notes	'	'
Stated interest rate	4.20%	4.20%

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies	'
	Significant Accounting Policies
	Business
	IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to its customers’ specifications. IDEX's products are sold in niche markets to a wide range of industries throughout the world. The Company’s products include industrial pumps, compressors, flow meters, injectors and valves, and related controls for use in a wide variety of process applications; precision fluidics solutions, including pumps, valves, degassing equipment, corrective tubing, fittings, and complex manifolds, precision photonic solutions, optical filters and specialty medical equipment and devices used in life science applications; precision-engineered equipment for dispensing, metering and mixing paints; refinishing equipment; and engineered products for industrial and commercial markets, including fire and rescue, transportation equipment, oil and gas, electronics, and communications. These activities are grouped into three reportable segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products.
	Principles of Consolidation
	The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for doubtful accounts, inventory valuation, recoverability of long-lived assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions.
	Revenue Recognition
	The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable, and collectability of the sales price is reasonably assured. For product sales, delivery does not occur until the products have been shipped and risk of loss has been transferred to the customer. Revenue from services is recognized when the services are provided or ratably over the contract term. Some arrangements with customers may include multiple deliverables, including the combination of products and services. In such cases the Company has identified these as separate elements in accordance with ASC 605-25 and recognizes revenue consistent with the policy for each separate element based on the relative selling price method. Revenues from certain long-term contracts are recognized on the percentage-of-completion method. Percentage-of-completion is measured principally by the percentage of costs incurred to date for each contract to the estimated total costs for such contract at completion. Provisions for estimated losses on uncompleted long-term contracts are made in the period in which such losses are determined. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised in the near-term. Such revisions to costs and income are recognized in the period in which the revisions are determined.
	The Company records allowances for discounts, product returns and customer incentives at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company.
	Shipping and Handling Costs
	Shipping and handling costs are included in cost of sales and are recognized as a period expense during the period in which they are incurred.
	Advertising Costs
	Advertising costs of $14.6 million, $15.3 million and $13.4 million for 2013, 2012 and 2011, respectively, are expensed as incurred within Selling, general and administrative expenses.
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments purchased with an original maturity of 90 days or less to be cash and cash equivalents.
	Allowance for Doubtful Accounts
	The Company maintains allowances for doubtful accounts for estimated losses as a result of customer’s inability to make required payments. Management evaluates the aging of the accounts receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of accounts receivables that may not be collected in the future and records the appropriate provision.
	Inventories
	The Company states inventories at the lower of cost or market. Cost, which includes material, labor, and factory overhead, is determined on a FIFO basis. We make adjustments to reduce the cost of inventory to its net realizable value, if required, at the business unit level for estimated excess, obsolescence or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes.
	Impairment of Long-Lived Assets
	Long-lived assets are reviewed for impairment upon the occurrence of events or changes in circumstances that indicate that the carrying value of the assets may not be recoverable, as measured by comparing their net book value to the projected undiscounted future cash flows generated by their use. Impaired assets are recorded at their estimated fair value based on a discounted cash flow analysis.
	Goodwill and Indefinite-Lived Intangible Assets
	In accordance with ASC 350, the Company reviews the carrying value of goodwill and indefinite-lived intangible assets annually on October 31, or upon the occurrence of events or changes in circumstances that indicate that the carrying value of the goodwill or intangible assets may not be recoverable. The Company evaluates the recoverability of these assets based on the estimated fair value of each of the fifteen reporting units and the indefinite-lived intangible asset. See Note 4 for a further discussion on goodwill and intangible assets.
	Borrowing Expenses
	Expenses incurred in securing and issuing debt are capitalized and included in Other noncurrent assets. These assets are amortized over the life of the related borrowing and the related amortization is included in Interest expense in the Consolidated Statements of Operations.
	Earnings per Common Share
	Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of shares of common stock (basic) plus common stock equivalents (diluted) outstanding during the year. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, unvested shares, performance share units, and shares issuable in connection with certain deferred compensation agreements ("DCUs").
	ASC 260 concludes that all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding unvested shares are participating securities. Accordingly, earnings per common share were computed using the two-class method prescribed by ASC 260. Net income attributable to common shareholders was reduced by $1.2 million, $0.1 million and $1.2 million in 2013, 2012 and 2011, respectively.
	Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows:
		2013	2012	2011
		(In thousands)
	Basic weighted average common shares outstanding	81,517	82,689	82,145
	Dilutive effect of stock options, unvested shares, performance share units and DCUs	972	952	1,398
	Diluted weighted average common shares outstanding	82,489	83,641	83,543
	Options to purchase approximately zero, 1.2 million and 0.7 million shares of common stock in 2013, 2012 and 2011, respectively, were not included in the computation of diluted EPS because the effect of their inclusion would have been antidilutive.
	Share-Based Compensation
	The Company accounts for share-based payments in accordance with ASC 718. Accordingly, the Company expenses the fair value of awards made under its share-based compensation plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants. See Note 13 for further discussion on share-based compensation.
	Depreciation and Amortization
	Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives:
	Land improvements	8 to 12 years
	Buildings and improvements	8 to 30 years
	Machinery, equipment and other	3 to 12 years
	Office and transportation equipment	3 to 10 years
	Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows:
	Patents	5 to 17 years
	Trade names	10 to 20 years
	Customer relationships	4.5 to 20 years
	Non-compete agreements	2.5 to 3 years
	Unpatented technology and other	4.5 to 20 years
	Research and Development Expenditures
	Costs associated with research and development are expensed in the period incurred and are included in Cost of sales within the Consolidated Statements of Operations. Research and development expenses, which include costs associated with developing new products and major improvements to existing products, were $33.0 million, $36.4 million and $36.0 million in 2013, 2012 and 2011, respectively.
	Foreign Currency Translation
	The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date. Income statement amounts have been translated using the average exchange rate for the year. The gains and losses resulting from changes in exchange rates from year to year have been reported in Accumulated other comprehensive loss in the Consolidated Balance Sheets. The effect of transaction gains and losses is reported within Other income (expense)-net in the Consolidated Statements of Operations.
	Income Taxes
	Income tax expense includes United States, state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and the tax basis of existing assets and liabilities and for loss carryforwards. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized.
	Concentration of Credit Risk
	The Company is not dependent on a single customer, the largest of which accounted for less than 2% of net sales for all years presented.
	Recently Issued Accounting Pronouncements
	In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-02 which requires additional disclosures regarding the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-02 requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. This guidance is effective for reporting periods beginning after December 15, 2012. The Company adopted this guidance effective January 1, 2013 and its adoption did not impact the consolidated financial position, results of operations or cash flows of the Company. See Note 14 for a further discussion on other comprehensive income (loss).

Restructuring

Restructuring	12 Months Ended
	Dec. 31, 2013
Restructuring and Related Activities [Abstract]	'
Restructuring	'
	Restructuring
	During 2012 and 2011 the Company recorded restructuring costs as a part of the 2011 restructuring initiatives that support the implementation of key strategic efforts designed to facilitate long-term sustainable growth through cost reduction actions, primarily consisting of employee reductions and facility rationalization. The costs incurred related to these initiatives are included in Restructuring expenses in the Consolidated Statements of Operations while the related accruals are included in Accrued expenses in the Consolidated Balance Sheets. Severance costs primarily consist of severance benefits through payroll continuation, COBRA subsidies, outplacement services, conditional separation costs and employer tax liabilities, while exit costs primarily consist of asset disposals or impairments, the termination of a defined benefit plan, legal costs and relocation charges.
	2011 Initiatives
	During 2012 and 2011 the Company recorded pre-tax restructuring expenses totaling $32.5 million and $12.3 million, respectively, related to our 2011 restructuring initiative for exit costs and employee severance related to employee reductions across various functional areas as well as facility rationalization. The 2011 restructuring initiatives included severance benefits for 491 employees in 2012 and 292 employees in 2011. The 2011 initiative was completed by the end of 2012 and no further restructuring is currently planned. Severance payments were fully paid in 2013 using cash from operations.
	Pre-tax restructuring expenses by segment, for 2012, were as follows:
		Severance			Exit Costs		Total
		Costs
		(In thousands)
	Fluid & Metering Technologies	$	6,226		$	36	$	6,262
	Health & Science Technologies	11,223			3,521		14,744
	Fire & Safety/Diversified Products	3,226			5,114		8,340
	Corporate/Other	2,844			283		3,127
	Total restructuring costs	$	23,519		$	8,954	$	32,473
	Pre-tax restructuring expenses by segment, for 2011, were as follows:
		Severance			Exit Costs		Total
		Costs
		(In thousands)
	Fluid & Metering Technologies	$	2,800		$	61	$	2,861
	Health & Science Technologies	2,007			123		2,130
	Fire & Safety/Diversified Products	4,430			797		5,227
	Corporate/Other	2,096			—		2,096
	Total restructuring costs	$	11,333		$	981	$	12,314
	Restructuring accruals of $10.9 million at December 31, 2012 are reflected in Accrued expenses in our Consolidated Balance Sheets as follows:
		2011
		Initiative
		(In thousands)
	Balance at January 1, 2012	$	5,875
	Restructuring expenses	32,473
	Payments, utilization and other	(27,461		)
	Balance at December 31, 2012	10,887
	Restructuring expenses	—
	Payments, utilization and other	(10,887		)
	Balance at December 31, 2013	$	—

Balance_Sheet_Components

Balance Sheet Components	12 Months Ended
	Dec. 31, 2013
Additional Financial Information Disclosure [Abstract]	'
Balance Sheet Components	'
	Balance Sheet Components
		December 31,
		2013			2012
		(In thousands)
	RECEIVABLES
	Customers	$	255,992		$	257,114
	Other	3,075			4,577
	Total	259,067			261,691
	Less allowance for doubtful accounts	5,841			5,596
	Total receivables — net	$	253,226		$	256,095
	INVENTORIES
	Raw materials and components parts	$	133,470		$	139,229
	Work in process	41,895			33,025
	Finished goods	55,602			62,696
	Total	$	230,967		$	234,950
	PROPERTY, PLANT AND EQUIPMENT
	Land and improvements	$	32,723		$	31,787
	Buildings and improvements	150,316			141,952
	Machinery, equipment and other	300,858			288,542
	Office and transportation equipment	95,923			95,920
	Construction in progress	9,201			12,040
	Total	589,021			570,241
	Less accumulated depreciation and amortization	375,533			351,080
	Total property, plant and equipment — net	$	213,488		$	219,161
	ACCRUED EXPENSES
	Payroll and related items	$	63,297		$	55,618
	Management incentive compensation	20,949			15,974
	Income taxes payable	11,746			10,284
	Insurance	7,741			8,974
	Warranty	4,888			4,875
	Deferred revenue	9,455			9,682
	Restructuring	—			10,887
	Liability for uncertain tax positions	1,201			2,679
	Accrued interest	1,354			1,713
	Contingent consideration for acquisition	—			3,528
	Other	30,120			25,962
	Total accrued expenses	$	150,751		$	150,176
	OTHER NONCURRENT LIABILITIES
	Pension and retiree medical obligations	$	67,777		$	96,853
	Liability for uncertain tax positions	4,624			4,989
	Deferred revenue	5,578			6,534
	Contingent consideration for acquisition	—			5,515
	Other	15,087			14,484
	Total other noncurrent liabilities	$	93,066		$	128,375
		2013			2012			2011
		(In thousands)
	VALUATION AND QUALIFYING ACCOUNTS(1)
	Beginning balance January 1	$	5,596		$	5,860		$	5,322
	Charged to costs and expenses, net of recoveries	2,288			653			1,044
	Utilization	(1,921		)	(1,151		)	(917		)
	Currency translation and other	(122		)	234			411
	Ending balance December 31	$	5,841		$	5,596		$	5,860
	-1	Includes provision for doubtful accounts, sales returns and sales discounts granted to customers.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets	'
	Goodwill and Intangible Assets
	The changes in the carrying amount of goodwill for 2013 and 2012, by business segment, were as follows:
		Fluid &			Health &			Fire &  Safety/			Total
		Metering			Science			Diversified
		Technologies			Technologies			Products
		(In thousands)
	Goodwill	$	541,640		$	648,906		$	270,910		$	1,461,456
	Accumulated impairment losses	—			—			(30,090		)	(30,090		)
	Balance at January 1, 2012	541,640			648,906			240,820			1,431,366
	Acquisition adjustments	—			1,424			—			1,424
	Acquisitions (Note 12)	—			50,387			—			50,387
	Foreign currency translation	3,406			2,307			3,378			9,091
	Goodwill impairment	(20,721		)	(149,820		)	—			(170,541		)
	Balance at December 31, 2012	524,325			553,204			244,198			1,321,727
	Acquisitions (Note 12)	—			17,994			—			17,994
	Foreign currency translation	3,719			477			5,539			9,735
	Balance at December 31, 2013	$	528,044		$	571,675		$	249,737		$	1,349,456
	ASC 350 requires that goodwill be tested for impairment at the reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. Goodwill represents the purchase price in excess of the net amount assigned to assets acquired and liabilities assumed.
	Goodwill and other acquired intangible assets with indefinite lives were tested for impairment as of October 31, 2013, the Company's annual impairment date. In assessing the fair value of the reporting units, the Company considers both the market approach and income approach. Under the market approach, the fair value of the reporting unit is based on comparing the reporting unit to comparable publicly traded companies. Under the income approach, the fair value of the reporting unit is based on the present value of estimated future cash flows. The income approach is dependent on a number of significant management assumptions including estimates of operating results, capital expenditures, other operating costs and discount rates. Weighting was equally attributed to both the market and income approaches (50% each) in arriving at the fair value of the reporting units.
	In 2013, there were no triggering events or changes in circumstances that would have required a review other than as of our annual test date.  Based on the results of our measurement at October 31, 2013, all reporting units had a fair value that was significantly in excess of carrying value, except for our IOP reporting unit, which had a fair value greater than 10% above carrying value.  The IOP reporting unit was written down to its fair value in 2012 as result of our goodwill impairment and thus the fair value continues to be near the carrying value.  In 2012, as a result of our annual impairment test for the IOP reporting unit and as a result of the reorganization of certain FMT reporting units, the Company determined that the fair value of the IOP and WST reporting units was less than the carrying value of the net assets of the reporting units, and thus the Company performed step two of the goodwill impairment test. In step two of the goodwill impairment test, the Company determined the implied fair value of the goodwill and compared it to the carrying value, which resulted in a $149.8 million goodwill impairment charge at the IOP reporting unit and a $20.7 million goodwill impairment charge at the WST reporting unit.
	The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2013 and 2012:
		At December 31, 2013											At December 31, 2012
		Gross			Accumulated			Net			Weighted		Gross		Accumulated			Net
		Carrying			Amortization						Average		Carrying		Amortization
		Amount									Life		Amount
					(In thousands)										(In thousands)
	Amortizable intangible assets:
	Patents	$	10,673		$	(5,179	)	$	5,494		11		$	10,650	$	(4,273	)	$	6,377
	Trade names	104,582			(28,310		)	76,272			16		103,113		(21,603		)	81,510
	Customer relationships	242,674			(121,092		)	121,582			10		230,196		(93,273		)	136,923
	Non-compete agreements	3,769			(3,272		)	497			3		3,505		(2,827		)	678
	Unpatented technology	75,528			(32,905		)	42,623			11		74,758		(24,211		)	50,547
	Other	6,958			(4,299		)	2,659			10		6,841		(3,604		)	3,237
	Total amortizable intangible assets	444,184			(195,057		)	249,127					429,063		(149,791		)	279,272
	Unamortized intangible assets:
	Banjo trade name	62,100			—			62,100					62,100		—			62,100
	Total intangible assets	$	506,284		$	(195,057	)	$	311,227				$	491,163	$	(149,791	)	$	341,372
	The unamortized Banjo trade name was determined to be an indefinite lived intangible asset which is tested for impairment on an annual basis in accordance with ASC 350 or more frequently if events or changes in circumstances indicate that the asset might be impaired. The Company uses the relief-from-royalty method, a form of the income approach. The relief-from-royalty method is dependent of a number of significant management assumptions, including estimates of revenues, royalty rates and discount rates.
	In 2013, there were no triggering events or changes in circumstances that would have required a review other than as of our annual test date and the Company concluded that the fair value of the Banjo trade name was in excess of the carrying value as of October 31, 2013.
	In 2012, as a result of our annual impairment test, the Company concluded that the fair value of the CVI Melles Griot trade names within the IOP reporting unit was less than the carrying value, resulting in a $21.0 million impairment charge. The Company also determined that the CVI Melles Griot trade names no longer had an indefinite life and reclassified the remaining $26.0 million to definite lived assets that will be amortized over a remaining useful life of 15 years.
	A long-lived asset impairment exists when the carrying amount of the asset exceeds its fair value. Assessments of possible impairments of long-lived assets are made when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable through future operations. The amount and timing of impairment charges for these assets require the estimation of future cash flows and the fair value of the related assets. In 2013, the Company concluded that certain long lived assets had a fair value that was less than the carrying value of the assets, resulting in $2.7 million of impairment charges. In 2012, the Company concluded that certain long lived assets within the WST reporting unit had a fair value that was less than the carrying value of the assets, resulting in a $7.0 million impairment charge.
	Amortization of intangible assets was $44.3 million, $41.5 million and $35.5 million in 2013, 2012 and 2011, respectively. Based on intangible asset balances as of December 31, 2013, amortization expense is expected to approximate $43.3 million in 2014, $41.1 million in 2015, $39.1 million in 2016, $30.0 million in 2017 and $18.3 million in 2018.

Borrowings

Borrowings	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Borrowings	'
	Borrowings
	Borrowings at December 31, 2013 and 2012 consisted of the following:
		2013		2012
		(In thousands)
	Revolving Facility	$	10,000	$	21,000
	4.2% Senior Notes, due December 2021	349,272		349,197
	4.5% Senior Notes, due December 2020	298,828		298,689
	2.58% Senior Euro Notes, due June 2015	111,505		107,042
	Other borrowings	4,271		10,648
	Total borrowings	773,876		786,576
	Less current portion	1,871		7,335
	Total long-term borrowings	$	772,005	$	779,241
	On June 27, 2011, the Company and certain of its subsidiaries entered into a credit agreement (the “Credit Agreement”), as borrowers with Bank of America, N.A., as administrative agent, swing line lender and an issuer of letters of credit, and other lenders party thereto which provided for a new revolving credit facility (the “Revolving Facility”). The Revolving Facility replaced the Company’s previous $600.0 million credit facility, which expired in December 2011.
	The Revolving Facility is in an aggregate principal amount of $700.0 million with a maturity date of June 27, 2016. Up to $75.0 million of the Revolving Facility is available for the issuance of letters of credit. Additionally, up to $25.0 million of the Revolving Facility is available to the Company for swing line loans, available on a same-day basis.
	Proceeds of the Revolving Facility are available for working capital and other general corporate purposes, including refinancing existing debt of the Company and its subsidiaries. The Company may request increases in the lending commitments under the Credit Agreement, but the aggregate lending commitments may not exceed $950.0 million. The Company has the right, subject to certain conditions set forth in the Credit Agreement, to designate certain foreign subsidiaries of the Company as borrowers under the Credit Agreement. In connection with any such designation, the Company is required to guarantee the obligations of any such subsidiaries under the Credit Agreement. Under the Credit Agreement, Fast & Fluid Management Europe B.V., (“FME”) and IDEX UK Ltd. (“IDEX UK”) were approved by the lenders as designated borrowers. At December 31, 2012, FME and IDEX UK had no borrowings under the Revolving Facility.
	Borrowings under the Revolving Facility bear interest, at either an alternate base rate or an adjusted LIBOR rate plus, in each case, an applicable margin. Such applicable margin is based on the Company’s senior, unsecured, long-term debt rating and can range from .875% to 1.70%. Based on the Company’s credit rating at December 31, 2013, the applicable margin was 1.05%. Interest is payable (a) in the case of base rate loans, quarterly, and (b) in the case of LIBOR rate loans, on the maturity date of the borrowing, or quarterly from the effective date for borrowings exceeding three months. An annual Revolving Facility fee, also based on the Company’s credit rating, is currently 20 basis points and is payable quarterly.
	The Credit Agreement contains affirmative and negative covenants that the Company believes are usual and customary for senior unsecured credit agreements, including a financial covenant requiring a maximum leverage ratio of a 3.25 to 1.0, which is the ratio of the Company’s consolidated total debt to its consolidated EBITDA, each as defined in the Credit Agreement.
	The Credit Agreement also contains customary events of default (subject to grace periods, as appropriate) including among others: nonpayment of principal, interest or fees; breach of the representations or warranties in any material respect; breach of the financial, affirmative or negative covenants; payment default on, or acceleration of, other material indebtedness; bankruptcy or insolvency; material judgments entered against the Company or any of its subsidiaries; certain specified events under the Employee Retirement Income Security Act of 1974, as amended; certain changes in control of the Company; and the invalidity or unenforceability of the Credit Agreement or other documents associated with the Credit Agreement.
	At December 31, 2013, $10.0 million was outstanding under the Revolving Facility, with $8.7 million of outstanding letters of credit, resulting in net available borrowing capacity under the Revolving Facility at December 31, 2013 of approximately $681.3 million.
	On June 9, 2010, the Company completed a private placement of €81.0 million ($96.8 million) aggregate principal amount of 2.58% Series 2010 Senior Euro Notes due June 9, 2015 (“2.58% Senior Euro Notes”) pursuant to a Master Note Purchase Agreement, dated June 9, 2010 (the “Purchase Agreement”). The Purchase Agreement provides for the issuance of additional series of notes in the future, provided that the aggregate principal amount outstanding under the agreement at any time does not exceed $750.0 million. The 2.58% Senior Euro Notes bear interest at a rate of 2.58% per annum, which is payable semi-annually in arrears on each June 9th and December 9th and will mature on June 9, 2015. The 2.58% Senior Euro Notes are unsecured obligations of the Company and rank pari passu in right of payment with all of the Company’s other senior debt. The Company may at any time prepay all or any portion of the 2.58% Senior Euro Notes; provided that any such portion is greater than 5% of the aggregate principal amount of Notes then outstanding under the Purchase Agreement. In the event of a prepayment, the Company would be required to pay an amount equal to par plus accrued interest plus a make-whole premium. The Purchase Agreement contains certain covenants that restrict the Company’s ability to, among other things, transfer or sell assets, create liens and engage in certain mergers or consolidations. In addition, the Company must comply with a leverage ratio and interest coverage ratio as set forth in the Purchase Agreement. The Purchase Agreement provides for customary events of default. In the case of an event of default arising from specified events of bankruptcy or insolvency, all outstanding 2.58% Senior Euro Notes will become due and payable immediately without further action or notice. In the case of payment events of defaults, any holder of the 2.58% Senior Euro Notes affected thereby may declare all the 2.58% Senior Euro Notes held by it due and payable immediately. In the case of any other event of default, a majority of the holders of the 2.58% Senior Euro Notes may declare all the 2.58% Senior Euro Notes to be due and payable immediately.
	On December 6, 2010, the Company completed a public offering of $300.0 million 4.5% senior notes due December 15, 2020 (“4.5% Senior Notes”). The net proceeds from the offering of $295.7 million, after deducting a $1.6 million issuance discount, a $1.9 million underwriting commission and $0.8 million offering expenses, were used to repay $250.0 million of outstanding bank indebtedness, with the balance used for general corporate purposes. The 4.5% Senior Notes bear interest at a rate of 4.5% per annum, which is payable semi-annually in arrears on each June 15th and December 15th. The Company may redeem all or a portion of the 4.5% Senior Notes at any time prior to maturity at the redemption prices set forth in the Note Indenture governing the 4.5% Senior Notes. The Company may issue additional debt from time to time pursuant to the Indenture. The Indenture and 4.5% Senior Notes contain covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale-leaseback transactions, and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all the Company’s assets. The terms of the 4.5% Senior Notes also require the Company to make an offer to repurchase the 4.5% Senior Notes upon a change of control triggering event (as defined in the Indenture) at a price equal to 101% of their principal amount plus accrued and unpaid interest, if any.
	On December 9, 2011, the Company completed a public offering of $350.0 million 4.2% senior notes due December 15, 2021 (“4.2% Senior Notes”). The net proceeds from the offering of $346.2 million, after deducting a $0.9 million issuance discount, a $2.3 million underwriting commission and $0.6 million offering expenses, were used to repay $306.0 million of outstanding bank indebtedness, with the balance used for general corporate purposes. The 4.2% Senior Notes bear interest at a rate of 4.2% per annum, which is payable semi-annually in arrears on each June 15th and December 15th. The Company may redeem all or a portion of the 4.2% Senior Notes at any time prior to maturity at the redemption prices set forth in the Note Indenture governing the 4.2% Senior Notes. The Company may issue additional debt from time to time pursuant to the Indenture. The Indenture and 4.2% Senior Notes contain covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale-leaseback transactions, and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all the Company’s assets. The terms of the 4.2% Senior Notes also require the Company to make an offer to repurchase the 4.2% Senior Notes upon a change of control triggering event (as defined in the Indenture) at a price equal to 101% of their principal amount plus accrued and unpaid interest, if any.
	Other borrowings of $4.3 million at December 31, 2013 were comprised of capital leases, debt at international locations maintained for working capital purposes and international debt as a result of acquisitions. Interest is payable on the outstanding debt balances at the international locations at rates ranging from 0.3% to 1.5% per annum.
	There are two key financial covenants that the Company is required to maintain in connection with the Revolving Facility and 2.58% Senior Euro Notes. The most restrictive financial covenants under these debt instruments require a minimum interest coverage ratio of 3.0 to 1 and a maximum leverage ratio of 3.25 to 1. At December 31, 2013, the Company was in compliance with both of these financial covenants. There are no financial covenants relating to the 4.5% Senior Notes or 4.2% Senior Notes; however, both are subject to cross-default provisions.
	Total borrowings at December 31, 2013 have scheduled maturities as follows (in thousands):
	2014	$	1,871
	2015	112,085
	2016	10,530
	2017	1,190
	2018	100
	Thereafter	648,100
	Total borrowings	$	773,876

Derivative_Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments	'
	Derivative Instruments
	The Company enters into cash flow hedges to reduce the exposure to variability in certain expected future cash flows. The type of cash flow hedges the Company enters into includes foreign currency contracts and interest rate exchange agreements that effectively convert a portion of floating-rate debt to fixed-rate debt and are designed to reduce the impact of interest rate changes on future interest expense.
	The effective portion of gains or losses on interest rate exchange agreements is reported in accumulated other comprehensive income (loss) in shareholders’ equity and reclassified into net income in the same period or periods in which the hedged transaction affects net income. The remaining gain or loss in excess of the cumulative change in the present value of future cash flows or the hedged item, if any, is recognized into net income during the period of change.
	Fair values relating to derivative financial instruments reflect the estimated amounts that the Company would receive or pay to sell or buy the contracts based on quoted market prices of comparable contracts at each balance sheet date.
	On April 15, 2010, the Company entered into a forward starting interest rate contract with a notional amount of $300.0 million with a settlement date in December 2010. This contract was entered into in anticipation of the issuance of the 4.5% Senior Notes and was designed to lock in the market interest rate as of April 15, 2010. In December 2010, the Company settled and paid this interest rate contract for $31.0 million. The $31.0 million is being amortized into interest expense over the 10 year term of the 4.5% Senior Notes, which results in an effective interest rate of 5.8%.
	On July 12, 2011, the Company entered into a forward starting interest rate contract with a notional amount of $350.0 million and a settlement date of September 30, 2011. This contract was entered into in anticipation of the issuance of the 4.2% Senior Notes and was designed to lock in the market interest rate as of July 12, 2011. On September 29, 2011, the Company settled this interest rate contract for $34.7 million with a payment made on October 3, 2011. Simultaneously, the Company entered into a separate interest rate contract with a notional amount of $350.0 million and a settlement date of February 28, 2012. The contract was entered into in anticipation of the expected issuance of the 4.2% Senior Notes and was designed to maintain the market rate as of July 12, 2011. In December 2011, the Company settled and paid the September interest rate contract for $4.0 million, resulting in a total settlement of $38.7 million. Of the $38.7 million, $0.8 million was recognized as other expense in 2011 and the balance of $37.9 million is being amortized into interest expense over the 10 year term of the 4.2% Senior Notes, which results in an effective interest rate of 5.3%.
	As of December 31, 2013 and 2012, the Company did not have any interest rate or foreign exchange contracts outstanding.
	The following table summarizes the gain (loss) recognized and the amounts and location of income (expense) and gain (loss) reclassified into income for interest rate contracts and foreign currency contracts for the year ended December 31, 2013 and 2012:
		Loss Recognized in						Income (Expense)									Income
		Other  Comprehensive Income						and Gain (Loss)									Statement
								Reclassified into Income									Caption
		Twelve Months Ended December 31,
		2013		2012		2011		2013			2012			2011
		(In thousands)
	Interest rate agreements	$	—	$	—	$	—	$	(7,430	)	$	(7,637	)	$	(3,570	)	Interest expense
	Approximately $7.2 million of the pre-tax amount included in accumulated other comprehensive loss in shareholders’ equity at December 31, 2013 will be recognized to net income over the next 12 months as the underlying hedged transactions are realized.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	Fair Value Measurements
	ASC 820 “Fair Value Measurements and Disclosures” defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The standard utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	•	Level 1:    Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	•	Level 2:    Inputs, other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
	•	Level 3:    Unobservable inputs that reflect the reporting entity’s own assumptions.
	The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheet at December 31, 2013 and 2012:
		Basis of Fair Value Measurements
		Balance at December 31, 2013			Level 1		Level 2		Level 3
		(In thousands)
	Money market investments	$	27,871		$	27,871	$	—	$	—
	Available for sale securities	3,255			3,255		—		—
		Balance at December 31, 2012			Level 1		Level 2		Level 3
		(In thousands)
	Money market investments	$	11,165		$	11,165	$	—	$	—
	Available for sale securities	2,862			2,862		—		—
	Contingent consideration	(9,043		)	—		—		(9,043		)
	There were no transfers of assets or liabilities between Level 1 and Level 2 in 2013 or 2012.
	In determining the initial fair value of the contingent consideration potentially due on the acquisition of Matcon, the Company used probability weighted estimates adjusted for the time value of money. At December 31, 2012, the Matcon contingent consideration liability was valued at $9.0 million, of which $8.4 million was recorded as part of the purchase price as of the opening balance sheet date and the remaining $0.6 was recognized in Selling, general and administrative expenses in the fourth quarter of 2012. At December 31, 2012, $3.5 million of the contingent consideration was included in Accrued expenses and $5.5 million of contingent consideration was recorded in Other noncurrent liabilities in the Consolidated Balance Sheet. In April 2013, the Company paid $3.8 million on the contingent consideration arrangement based on Matcon's 2012 operating results. In November 2013, the Company paid $1.1 million of the contingent consideration arrangement based on a settlement agreement with the sellers and the remaining $4.1 million was recognized as a benefit within Selling, general and administrative expenses.
	The carrying value of our cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximates their fair values because of the short term nature of these instruments. At December 31, 2013, the fair value of our Revolving Facility, 2.58% Senior Euro Notes, 4.5% Senior Notes and 4.2% Senior Notes, based on quoted market prices and current market rates for debt with similar credit risk and maturity, was approximately $772.9 million compared to the carrying value of $769.6 million. This fair value measurement is classified as Level 2 within the fair value hierarchy since it is determined based upon significant inputs observable in the market, including interest rates on recent financing transactions to entities with a credit rating similar to ours.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	The Company leases certain office facilities, warehouses and data processing equipment under operating leases. Rental expense totaled $18.9 million, $18.4 million and $19.0 million in 2013, 2012 and 2011, respectively.
	The aggregate future minimum lease payments for operating and capital leases as of December 31, 2013 were as follows:
		Operating			Capital
		(In thousands)
	2014	$	15,426		$	564
	2015	11,811			604
	2016	7,742			548
	2017	5,177			1,192
	2018	3,964			100
	2019 and thereafter	5,945			—
		$	50,065		$	3,008
	Warranty costs are provided for at the time of sale. The warranty provision is based on historical costs and adjusted for specific known claims. A rollforward of the warranty reserve is as follows:
		2013			2012			2011
		(In thousands)
	Beginning balance January 1st	$	4,875		$	4,417		$	3,831
	Provision for warranties	3,845			5,398			4,648
	Claim settlements	(3,865		)	(5,214		)	(4,443		)
	Other adjustments, including acquisitions and currency translation	33			274			381
	Ending balance December 31st	$	4,888		$	4,875		$	4,417
	The Company is party to various legal proceedings arising in the ordinary course of business, none of which is expected to have a material effect on its business, financial condition, results of operations or cash flow.

Common_and_Preferred_Stock

Common and Preferred Stock	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Common and Preferred Stock	'
	Common and Preferred Stock
	On November 8, 2013, the Company’s Board of Directors approved an increase in the authorized level for repurchases of common stock by $300.0 million. Repurchases under the program will be funded with future cash flow generation. During 2013, the Company purchased a total of 2.9 million shares at a cost of $167.5 million compared to 2.2 million shares purchased at a cost of $89.6 million in 2012. As of December 31, 2013 there was $368 million remaining under authorized repurchases.
	At December 31, 2013 and 2012, the Company had 150 million shares of authorized common stock, with a par value of $.01 per share and 5 million shares of authorized preferred stock with a par value of $.01 per share. No preferred stock was issued as of December 31, 2013 and 2012.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	Pretax income for 2013, 2012 and 2011 was taxed in the following jurisdictions:
		2013			2012			2011
		(In thousands)
	Domestic	$	233,530		$	65,738		$	192,857
	Foreign	119,599			20,466			81,024
	Total	$	353,129		$	86,204		$	273,881
	The provision (benefit) for income taxes for 2013, 2012 and 2011, was as follows:
		2013			2012			2011
		(In thousands)
	Current
	U.S.	$	59,707		$	59,811		$	48,823
	State and local	8,123			5,764			3,434
	Foreign	33,240			20,228			31,343
	Total current	101,070			85,803			83,600
	Deferred
	U.S.	1,500			(31,246		)	4,792
	State and local	(55		)	(2,377		)	(1,103		)
	Foreign	(4,601		)	(3,606		)	(7,265		)
	Total deferred	(3,156		)	(37,229		)	(3,576		)
	Total provision for income taxes	$	97,914		$	48,574		$	80,024
	Deferred tax assets (liabilities) at December 31, 2013 and 2012 were:
		2013			2012
		(In thousands)
	Employee and retiree benefit plans	$	27,361		$	38,401
	Depreciation and amortization	(175,894		)	(170,630		)
	Inventories	9,627			10,851
	Allowances and accruals	9,632			7,629
	Interest rate exchange agreement	18,165			20,856
	Other	4,636			7,059
	Total	$	(106,473	)	$	(85,834	)
	The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2013 and 2012 were:
		2013			2012
		(In thousands)
	Deferred tax asset — other current assets	$	34,151		$	32,293
	Deferred tax asset — other noncurrent assets	4,284			3,222
	Total deferred tax assets	38,435			35,515
	Deferred tax liability — accrued expenses	—			—
	Noncurrent deferred tax liability — deferred income taxes	(144,908		)	(121,349		)
	Total deferred tax liabilities	(144,908		)	(121,349		)
	Net deferred tax liabilities	$	(106,473	)	$	(85,834	)
	The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate to pretax income. The computed amount and the differences for 2013, 2012 and 2011 are shown in the following table:
		2013			2012			2011
		(In thousands)
	Pretax income	$	353,129		$	86,204		$	273,881
	Provision for income taxes:
	Computed amount at statutory rate of 35%	$	123,595		$	30,171		$	95,858
	State and local income tax (net of federal tax benefit)	4,382			2,406			1,515
	Taxes on non-U.S. earnings-net of foreign tax credits	(9,683		)	1,189			(4,522		)
	Effect of flow-through entities	(7,267		)	(7,846		)	(6,922		)
	Asset impairments	—			28,524			—
	U.S. business tax credits	(1,516		)	—			(917		)
	Domestic activities production deduction	(6,217		)	(5,267		)	(4,589		)
	Other	(5,380		)	(603		)	(399		)
	Total provision for income taxes	$	97,914		$	48,574		$	80,024
	The Company has $597 million and $468 million of undistributed earnings of non-U.S. subsidiaries as of December 31, 2013 and 2012 , respectively.  No deferred U.S. income taxes have been provided on these earnings as they are considered to be reinvested for an indefinite period of time or will be repatriated when it is tax effective to do so.  If these amounts were distributed to the U.S., in the form of dividends or otherwise, we would be subject to additional U.S. income taxes, which could be material.  Determination of the amount of unrecognized deferred income tax liabilities on these earnings is not practicable because of the complexities with the hypothetical calculation, and the amount of liability, if any, is dependent on circumstances if and when remittance occurs. During the year ended December 31, 2013, the Company repatriated $11.7 million of foreign earnings resulting in $0.9 million of incremental income tax expense.
	A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2013, 2012 and 2011 are shown in the following table:
		2013			2012			2011
		(In thousands)
	Beginning balance January 1st	$	6,506		$	5,548		$	6,440
	Gross increases for tax positions of prior years	1,357			3,017			1,828
	Gross decreases for tax positions of prior years	(99		)	(98		)	(1,595		)
	Settlements	(1,219		)	—			(338		)
Lapse of statute of limitations	(1,421		)	(1,961		)	(787		)
Ending balance December 31st	$	5,124		$	6,506		$	5,548
We recognize interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2013, 2012 and 2011, we had approximately $0.5 million, $0.7 million and $0.5 million, respectively, of accrued interest related to uncertain tax positions. As of December 31, 2013, 2012 and 2011, we had approximately $0.2 million, $0.5 million and $0.2 million, respectively, of accrued penalties related to uncertain tax positions.
The total amount of unrecognized tax benefits that would affect our effective tax rate if recognized is $4.5 million, $5.8 million and $5.0 million as of December 31, 2013, 2012 and 2011, respectively. The tax years 2007-2012 remain open to examination by major taxing jurisdictions. Due to the potential for resolution of federal, state and foreign examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Company’s gross unrecognized tax benefits balance may change within the next 12 months by a range of zero to $1.2 million.
The Company had net operating loss and credit carry forwards for U.S. federal purposes at December 31, 2013 and 2012 of $9.4 and $13.9 million, respectively. For non-U.S. purposes, the Company had net operating loss carry forwards at December 31, 2013 and 2012 of $7.0 and $7.8 million, respectively. The federal net operating loss carry forwards are available for use against the Company’s consolidated federal taxable income and expire between 2018 and 2031. The entire balance of the non-U.S. net operating losses is available to be carried forward, with $2.7 million of these losses beginning to expire during the years 2018 through 2021. The remaining $4.3 million of such losses can be carried forward indefinitely.
At December 31, 2013 and 2012, the Company had a foreign capital loss carry forward of approximately $1.0 million and $1.0 million, respectively. The foreign capital loss can be carried forward indefinitely. At both December 31, 2013 and 2012, the Company has a valuation allowance against the deferred tax asset attributable to the foreign capital loss of $0.2 million. At December 31, 2013 and 2012, the Company had state net operating loss and credit carry forwards of approximately $22.4 million and $38.8 million, respectively. If unutilized, the state net operating loss will expire between 2020 and 2033. At December 31, 2013 and 2012, the Company recorded a valuation allowance against the deferred tax asset attributable to the state net operating loss of $0.7 million and $1.5 million, respectively.

Business_Segments_and_Geograph

Business Segments and Geographic Information	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Business Segments and Geographic Information	'
	Business Segments and Geographic Information
	IDEX has three reportable business segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products. Reporting units in the Fluid & Metering Technologies segment consist of: Banjo; Energy; CFP; DDPT and WST. Reporting units in the Health & Science Technologies segment consist of: Scientific Fluidics; IOP; Sealing Solutions; Gast; Micropump and MPT. Reporting units in the Fire & Safety/Diversified Products segment consist of: Fire Suppression; Rescue; Band-It; and Dispensing Equipment.
	The Fluid & Metering Technologies segment designs, produces and distributes positive displacement pumps, flow meters, injectors, and other fluid-handling pump modules and systems and provides flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural and energy industries. The Health & Science Technologies segment designs, produces and distributes a wide range of precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems used in beverage, food processing, pharmaceutical and cosmetics, pneumatic components and sealing solutions, including very high precision, low-flow rate pumping solutions required in analytical instrumentation, clinical diagnostics and drug discovery, high performance molded and extruded, biocompatible medical devices and implantables, air compressors used in medical, dental and industrial applications, optical components and coatings for applications in the fields of scientific research, defense, biotechnology, aerospace, telecommunications and electronics manufacturing, laboratory and commercial equipment used in the production of micro and nano scale materials, precision photonic solutions used in life sciences, research and defense markets, and precision gear and peristaltic pump technologies that meet exacting original equipment manufacturer specifications. The Fire & Safety/Diversified Products segment produces firefighting pumps and controls, rescue tools, lifting bags and other components and systems for the fire and rescue industry, engineered stainless steel banding and clamping devices used in a variety of industrial and commercial applications, and precision equipment for dispensing, metering and mixing colorants and paints used in a variety of retail and commercial businesses around the world.
	Information on the Company’s business segments is presented below, based on the nature of products and services offered. The Company evaluates performance based on several factors, of which operating income is the primary financial measure. Intersegment sales are accounted for at fair value as if the sales were to third parties.
		2013			2012			2011
		(In thousands)
	NET SALES
	Fluid & Metering Technologies
	External customers	$	870,720		$	829,320		$	830,821
	Intersegment sales	1,094			3,968			466
	Total segment sales	871,814			833,288			831,287
	Health & Science Technologies
	External customers	708,940			689,574			606,247
	Intersegment sales	5,710			5,661			1,653
	Total segment sales	714,650			695,235			607,900
	Fire & Safety/Diversified Products
	External customers	444,470			435,364			401,383
	Intersegment sales	579			1,689			1,042
	Total segment sales	445,049			437,053			402,425
	Intersegment eliminations	(7,383		)	(11,318		)	(3,161		)
	Total net sales	$	2,024,130		$	1,954,258		$	1,838,451
	OPERATING INCOME (LOSS)(1)
	Fluid & Metering Technologies(2)	$	211,256		$	146,650		$	164,818
	Health & Science Technologies(2)	136,707			(62,835		)	106,037
	Fire & Safety/Diversified Products	102,730			96,120			85,901
	Corporate office	(55,180		)	(51,717		)	(52,100		)
	Total operating income	395,513			128,218			304,656
	Interest expense	42,206			42,250			29,332
	Other income (expense) - net	(178		)	236			(1,443		)
	Income before taxes	$	353,129		$	86,204		$	273,881
		2013			2012			2011
		(In thousands)
	ASSETS
	Fluid & Metering Technologies	$	1,025,352		$	1,023,143		$	1,072,023
	Health & Science Technologies	1,113,546			1,102,868			1,178,653
	Fire & Safety/Diversified Products	484,139			488,886			442,400
	Corporate office	264,540			170,493			143,031
	Total assets	$	2,887,577		$	2,785,390		$	2,836,107
	DEPRECIATION AND AMORTIZATION(3)
	Fluid & Metering Technologies	$	27,633		$	29,637		$	32,368
	Health & Science Technologies	43,496			39,981			30,055
	Fire & Safety/Diversified Products	6,852			7,107			8,516
	Corporate office and other	1,353			1,587			1,447
	Total depreciation and amortization	$	79,334		$	78,312		$	72,386
	CAPITAL EXPENDITURES
	Fluid & Metering Technologies	$	11,581		$	13,535		$	12,543
	Health & Science Technologies	12,280			13,140			12,938
	Fire & Safety/Diversified Products	5,040			6,654			5,644
	Corporate office and other	2,635			2,191			3,423
	Total capital expenditures	$	31,536		$	35,520		$	34,548
	-1	Segment operating income excludes net unallocated corporate operating expenses.
	-2	Segment operating income includes asset impairment charges in 2012 of $27.7 million within the Fluid & Metering Technologies segment and $170.8 million within the Health & Science Technologies segment.
	-3	Excludes amortization of debt issuance expenses.
	Information about the Company’s operations in different geographical regions for the years ended December 31, 2013, 2012 and 2011 is shown below. Net sales were attributed to geographic areas based on location of the customer, and no country outside the U.S. was greater than 10% of total revenues.
		2013			2012			2011
		(In thousands)
	NET SALES
	U.S.	$	983,791		$	963,137		$	857,990
	Europe	521,491			479,744			492,125
	Asia	306,466			305,185			278,900
	Other countries	212,382			206,192			209,436
	Total net sales	$	2,024,130		$	1,954,258		$	1,838,451
	LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT
U.S.	$	124,880		$	127,425		$	124,102
Europe	63,018			64,137			63,433
Asia	24,590			26,320			24,570
Other countries	1,000			1,279			1,612
Total long-lived assets — net	$	213,488		$	219,161		$	213,717

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Acquisitions	'
	Acquisitions
	All of the Company’s acquisitions have been accounted for under ASC 805, Business Combinations. Accordingly, the accounts of the acquired companies, after adjustments to reflect fair values assigned to assets and liabilities, have been included in the consolidated financial statements from their respective dates of acquisition.
	2013 Acquisitions
	On March 18, 2013, the Company acquired the stock of FTL Seals Technology, Ltd (“FTL”). FTL specializes in the design and application of high integrity rotary seals, specialty bearings, and other custom products for the oil & gas, mining, power generation, and marine markets. Located in Leeds, England, FTL has annual revenues of approximately $22.5 million (£15.0 million). FTL, along with Precision Polymer Engineering (“PPE”), operates within the Health & Science Technologies segment as part of the Sealing Solutions group (formerly the Containment group) and will expand the range of PPE’s technology expertise and markets served. FTL was acquired for an aggregate purchase price of $34.5 million (£23.1 million) in cash. The entire purchase price was funded with borrowings under the Revolving Facility. Goodwill and intangible assets recognized as part of this transaction were $18.0 million and $13.0 million, respectively. The $18.0 million of goodwill is not deductible for tax purposes.
	The purchase price for FTL has been allocated to the assets acquired and liabilities assumed based on estimated fair values at the date of the acquisition. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. The Company is continuing to evaluate the initial purchase price allocations, as of the acquisition date, which will be adjusted as additional information relative to the fair values of the assets and liabilities of the business become known. Accordingly, management has used its best estimate in the initial purchase price allocation as of the date of these financial statements.
	The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values, is as follows:
	(In thousands)
	Accounts receivable	$	3,454
	Inventory	4,524
	Other current assets, net of cash acquired	131
	Property, plant and equipment	1,357
	Goodwill	17,994
	Intangible assets	13,016
	Total assets acquired	40,476
	Total liabilities assumed	(5,939		)
	Net assets acquired	$	34,537
	Acquired intangible assets consist of trade names, non-compete agreements, customer relationships and unpatented technology. The goodwill recorded for the acquisitions reflects the strategic fit and revenue and earnings growth potential of these businesses.
	The acquired intangible assets and weighted average amortization periods are as follows:
	(In thousands, except weighted average life)	Total			Weighted
					Average
					Life
	Trade names	$	1,005		15
	Non-compete agreements	224			3
	Customer relationships	10,950			9
	Unpatented technology	837			8
	2013 acquired intangible assets	$	13,016
	The Company incurred $1.4 million of acquisition-related transaction costs in 2013. These costs were recorded in selling, general and administrative expense and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. The Company incurred $1.8 million of non-cash acquisition fair value inventory charges in 2013. These charges were recorded in cost of sales.
	2012 Acquisitions
	On April 11, 2012, the Company acquired the stock of PPC. PPC specializes in optical components and coatings for applications in the fields of scientific research, aerospace, telecommunications and electronics manufacturing. Located in Boulder, Colorado, PPC operates within the Health & Science Technologies segment as a part of the IOP platform. The Company acquired PPC for an aggregate purchase price of $20.6 million in cash, which was funded from operations. Goodwill and intangible assets recognized as part of this transaction were $13.9 million and $5.1 million, respectively. The $13.9 million of goodwill is not deductible for tax purposes.
	On April 30, 2012, the Company acquired the stock of ERC. ERC is a leader in the manufacture of gas liquid separations and detection solutions for the life science, analytical instrumentation and clinical chemistry markets. ERC’s pioneering products include in-line membrane vacuum degassing solutions, refractive index detectors and ozone generation systems. ERC’s original equipment degassing solutions are considered the “standard” for many of the world’s leading instrument producers. Located in Kawaguchi, Japan, ERC operates within the Health & Science Technologies segment as part of the Scientific Fluidics platform. The Company acquired ERC for an aggregate purchase price of $18.0 million (¥1.47 billion), consisting of $13.3 million in cash and assumption of approximately $4.7 million of debt. The cash payment was financed with borrowings under the Revolving Facility. Goodwill and intangible assets recognized as part of this transaction were $8.5 million and $5.6 million, respectively. The $8.5 million of goodwill is not deductible for tax purposes.
	On July 20, 2012, the Company acquired the stock of Matcon. Matcon is a global leader in material processing solutions for high value powders used in the manufacture of pharmaceuticals, food, plastics, and fine chemicals. Matcon’s innovative products include the original cone valve powder discharge system and filling, mixing and packaging systems, all of which support their customers’ automation and process requirements. Matcon’s products are critical to their customers’ need to maintain clean, reliable and repeatable formulations of prepackaged foods and pharmaceuticals while helping them achieve lean and agile manufacturing. Located in Evesham, Worcestershire, England, Matcon operates within the Health & Science Technologies segment in the MPT platform. The Company acquired Matcon for an aggregate purchase price of $45.8 million (£29.1 million), consisting of $35.0 million in cash, $2.4 million of working capital adjustments paid in the second quarter of 2013, and contingent consideration valued at $8.4 million as of the opening balance sheet date. The contingent consideration amount is based on 2012 and 2013 earnings before interest, income taxes, depreciation and amortization for Matcon. In 2013, the Company paid $4.9 million for full settlement of the contingent consideration arrangement. Approximately $15.0 million of the purchase price cash payment was financed with borrowings under the Revolving Facility. Goodwill and intangible assets recognized as part of this transaction were $28.0 million and $14.1 million, respectively. The $28.0 million of goodwill is not deductible for tax purposes.
	The purchase price for PPC, ERC and Matcon were allocated to the assets acquired and liabilities assumed based on estimated fair values at the date of the acquisition.
	The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values, is as follows:
	(In thousands)	ERC			PPC			Matcon			Total
	Accounts receivable	$	5,766		$	877		$	7,768		$	14,411
	Inventory	4,224			932			604			5,760
	Other current assets, net of cash acquired	981			252			1,880			3,113
	Property, plant and equipment	2,738			1,936			5,695			10,369
	Goodwill	8,499			13,941			27,947			50,387
	Intangible assets	5,642			5,104			14,081			24,827
	Other assets	1,509			13			53			1,575
	Total assets acquired	29,359			23,055			58,028			110,442
	Total liabilities assumed	(16,074		)	(2,465		)	(12,215		)	(30,754		)
	Net assets acquired	$	13,285		$	20,590		$	45,813		$	79,688
	Acquired intangible assets consist of trade names, non-compete agreements, customer relationships and unpatented technology. The goodwill recorded for the acquisitions reflects the strategic fit and revenue and earnings growth potential of these businesses.
	The acquired intangible assets and weighted average amortization periods are as follows:
	(In thousands, except weighted average life)	Total			Weighted
					Average
					Life
	Trade names	$	8,973		15
	Non-compete agreements	470			3
	Customer relationships	11,343			6
	Unpatented technology	4,041			8
	2012 acquired intangible assets	$	24,827
	The Company incurred $2.7 million of acquisition-related transaction costs in 2012. These costs were recorded in selling, general and administrative expense and were related to completed transactions, pending transactions and potential transactions, including certain transactions that ultimately were not completed. During 2012, the Company recorded $0.9 million of fair value inventory charges associated with these acquisitions, which were recorded in cost of sales.
	2011 Acquisitions
	On January 31, 2011, the Company acquired the membership interests of AT Films. AT Films specializes in optical components and coatings for applications in the fields of scientific research, defense, aerospace, telecommunications and electronics manufacturing. AT Films’ core competence is the design and manufacture of filters, splitters, reflectors and mirrors with the precise physical properties required to support their customers’ most challenging and cutting-edge optical applications. Headquartered in Boulder, Colorado, AT Films operates within the Health & Science Technologies segment as a part of the IOP platform. The Company acquired AT Films for an aggregate purchase price of $34.5 million, consisting of $31.8 million in cash and contingent consideration valued at approximately $2.7 million as of the opening balance sheet date. Goodwill and intangible assets recognized as part of this transaction were $18.2 million and $11.4 million, respectively. The $18.2 million of goodwill is deductible for tax purposes.
	On March 11, 2011, the Company completed the acquisition of Microfluidics. Microfluidics is a global leader in the design and manufacture of laboratory and commercial equipment used in the production of micro and nano scale materials for the pharmaceutical and chemical markets. Microfluidics is the exclusive producer of the Microfluidizer family of high shear fluid processors for uniform particle size reduction, robust cell disruption and nanoparticle creation. Microfluidics operates within the Health & Science Technologies segment as a part of the MPT platform. The Company acquired Microfluidics for an aggregate purchase price of $18.5 million in cash. Goodwill and intangible assets recognized as part of this transaction were $5.9 million and $9.7 million, respectively. The $5.9 million of goodwill is not deductible for tax purposes.
	On June 10, 2011, the Company completed the acquisition of CVI Melles Griot (“CVI MG”). CVI MG is a global leader in the design and manufacture of precision photonic solutions used in the life sciences, research, semiconductor, security and defense markets. CVI MG’s innovative products are focused on the generation, control and productive use of light for a variety of key science and industrial applications. Products include specialty lasers and light sources, electro-optical components, specialty shutters and components. In addition, CVI MG produces critical components for life science research, electronics manufacturing, military and other industrial applications including lenses, mirrors, filters and polarizers. These components are utilized in a number of important applications such as spectroscopy, cytometry (cell counting), guidance systems for target designation, remote sensing, menology and optical lithography. CVI MG operates within the Health and Science Technologies segment as part of the IOP platform. The Company acquired CVI MG for an aggregate purchase price of $394.7 million, consisting of $393.3 million in cash and the assumption of approximately $1.4 million of debt. Approximately $365.0 million of the cash payment was financed with borrowings under the Revolving Facility. CVI MG is headquartered in Albuquerque, New Mexico, with manufacturing sites located on three continents. Goodwill and intangible assets recognized as part of this transaction were $208.5 million and $115.8 million, respectively. Approximately $117.7 million of goodwill is deductible for tax purposes.
	The purchase price for CVI MG, AT Films and Microfluidics was allocated to the assets acquired and liabilities assumed based on estimated fair values at the date of the acquisition.
	The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values, is as follows:
	(In thousands)	AT Films			Microfluidics			CVI MG			Total
	Accounts receivable	$	947		$	1,760		$	23,978		$	26,685
Inventory	852			2,226			52,868			55,946
Other current assets, net of cash acquired	73			816			7,562			8,451
Property, plant and equipment	5,019			567			31,049			36,635
Goodwill	18,220			5,853			208,540			232,613
Intangible assets	11,435			9,717			115,777			136,929
Other assets	2,731			548			2,112			5,391
Total assets acquired	39,277			21,487			441,886			502,650
Total liabilities assumed	(4,766		)	(2,951		)	(48,572		)	(56,289		)
Net assets acquired	$	34,511		$	18,536		$	393,314		$	446,361
Of the $136.9 million of acquired intangible assets, $47.0 million was assigned to the CVI Melles Griot trade name and was originally not subject to amortization, however, effective October 31, 2012, the Company began to amortize this asset over 15 years. The remaining $89.9 million of acquired intangible assets consist of patents, trade names, customer relationships, non-compete and unpatented technology. The goodwill recorded for the acquisitions reflects the strategic fit and revenue and earnings growth potential of these businesses.
The acquired intangible assets and weighted average amortization periods are as follows:
(In thousands, except weighted average life)	Total			Weighted
				Average
				Life
Patents	$	3,017		10
Trade names	4,168			15
Customer relationships	53,895			7
Non-compete agreements	793			2
Unpatented technology	28,048			6
2011 acquired intangible assets	$	89,921
The Company incurred $5.8 million of acquisition-related transaction costs in 2011. These costs were recorded in selling, general and administrative expense and were related to completed transactions, pending transactions and potential transactions, including certain transactions that ultimately were not completed.

ShareBased_Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Share-Based Compensation	'
	Share-Based Compensation
	The Company maintains two share-based compensation plans for executives, non-employee directors, and certain key employees that authorize the granting of stock options, unvested shares, unvested share units, and other types of awards consistent with the purpose of the plans. The number of shares authorized for issuance under the Company’s plans as of December 31, 2013 totals 10.6 million, of which 2.7 million shares were available for future issuance. Stock options granted under these plans are generally non-qualified, and are granted with an exercise price equal to the market price of the Company’s stock at the date of grant. The majority of the options issued to employees become exercisable in four equal installments, beginning one year from the date of grant, and generally expire 10 years from the date of grant. Stock options granted to non-employee directors cliff vest after one year. Unvested share and unvested share unit awards generally cliff vest after three years for employees and non-employee directors. The Company issued 0.2 million, 0.2 million and 0.3 million of unvested shares as compensation to key employees in 2013, 2012 and 2011, respectively.
	All unvested shares carry dividend and voting rights, and the sale of the shares is restricted prior to the date of vesting.
	Beginning in 2013, the Company granted performance share units to selected key employees that may be earned based on IDEX total shareholder return over the three-year period following the date of grant. Performance share units (referred to as “TSR awards”) are expected to be made annually and are paid out at the end of a three-year period based on the Company’s performance. Performance is measured by determining the percentile rank of the total shareholder return of IDEX common stock in relation to the total shareholder return of the S&P Midcap 400 Industrial Group for the three-year period following the date of grant. The payment of awards following the three-year award period will be based on performance achieved in accordance with the scale set forth in the plan agreement and may range from 0 percent to 200 percent of the initial grant. A target payout of 100 percent is earned if total shareholder return is equal to the 50th percentile of the S&P Midcap 400 Industrial Group. Performance share units earn dividend equivalents for the award period, which will be paid to participants with the award payout at the end of the period based on the actual number of performance share units that are earned. Payments made at the end of the award period will be in the form of stock for performance share units and will be in cash for dividend equivalents. During the year ended December 31, 2013, the Company granted approximately 0.1 million performance share units.
	The Company expenses the fair value of awards made under its share-based plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants.
	Weighted average option fair values and assumptions for the period specified are disclosed in the following table:
		Years Ended December 31,
		2013		2012		2011
	Weighted average fair value of grants	$12.97		$11.40		$12.30
	Dividend yield	1.57%		1.59%		1.46%
	Volatility	30.92%		32.00%		32.72%
	Risk-free interest rate	0.17% - 4.12%		0.17% - 3.96%		0.28% - 5.61%
	Expected life (in years)	5.86		5.98		6.14
	The assumptions are as follows:
	•	The Company estimated volatility using its historical share price performance over the contractual term of the option.
	•	The Company uses historical data to estimate the expected life of the option. The expected life assumption for the years ended December 31, 2013, 2012 and 2011 is an output of the Binomial lattice option-pricing model, which incorporates vesting provisions, rate of voluntary exercise and rate of post-vesting termination over the contractual life of the option to define expected employee behavior.
	•	The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option. For the years ended December 31, 2013, 2012 and 2011, we present the range of risk-free one-year forward rates, derived from the U.S. treasury yield curve, utilized in the Binomial lattice option-pricing model.
	•	The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the option.
	The Company’s policy is to recognize compensation cost on a straight-line basis, assuming forfeitures, over the requisite service period for the entire award. Additionally, the Company’s general policy is to issue new shares of common stock to satisfy stock option exercises or grants of unvested shares.
	Weighted average performance share unit fair values and assumptions for the period specified are disclosed in the following table:
		Year Ended December 31,
		2013
	Weighted average fair value of grants	$59.58
	Dividend yield	—%
	Volatility	28.99%
	Risk-free interest rate	0.40%
	Expected life (in years)	2.87
	The assumptions are as follows:
	•	The Company estimated volatility using its historical share price performance over the remaining performance period as of the grant date.
	•	Since Monte Carlo valuation is an open form model that uses an expected life commensurate with the performance period, the expected life of the performance share units was assumed to be the period from the grant date to the end of the performance period.
	•	The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant with a term commensurate with the remaining performance period.
	•	Total Shareholder Return is determined assuming that dividends are reinvested in the issuing entity over the performance period, which is mathematically equivalent to utilizing a 0% dividend yield.
	Total compensation cost for stock options is as follows:
		Years Ended December 31,
		2013				2012				2011
		(In thousands)
	Cost of goods sold	$	479			$	650			$	805
	Selling, general and administrative expenses	5,789				5,642				6,153
	Total expense before income taxes	6,268				6,292				6,958
	Income tax benefit	(2,016		)		(1,988		)		(2,208		)
	Total expense after income taxes	$	4,252			$	4,304			$	4,750
	Total compensation cost for unvested shares is as follows:
		Years Ended December 31,
		2013				2012				2011(1)
		(In thousands)
	Cost of goods sold	$	1,380			$	991			$	684
	Selling, general and administrative expenses	8,471				5,819				4,434
	Total expense before income taxes	9,851				6,810				5,118
	Income tax benefit	(2,296		)		(1,682		)		(1,827		)
	Total expense after income taxes	$	7,555			$	5,128			$	3,291
	-1	Reflects the forfeiture of unvested shares related to the Company’s transition to a new CEO in August 2011.
	Total compensation cost for performance share units is as follows:
		Year Ended December 31,
		2013
		(In thousands)
	Cost of goods sold	$	—
	Selling, general and administrative expenses	873
	Total expense before income taxes	873
	Income tax benefit	(280		)
	Total expense after income taxes	$	593
	Recognition of compensation cost was consistent with recognition of cash compensation for the same employees.
	As of December 31, 2013, there was $9.1 million, $12.3 million and $1.8 million of total unrecognized compensation cost related to stock options, time based shares and performance shares, respectively, that is expected to be recognized over a weighted-average period of 1.3 years, 1.0 year and 1.1 years, respectively.
	A summary of the Company’s stock option activity as of December 31, 2013, and changes during the year ended December 31, 2013 is presented in the following table:
Stock Options	Shares			Weighted				Weighted-Average		Aggregate
				Average				Remaining		Intrinsic
				Price				Contractual Term		Value
Outstanding at January 1, 2013	3,223,742			$	33.16			6.37		$	43,106,153
Granted	651,022			50.7
Exercised	(1,245,817	)		28.41
Forfeited/Expired	(112,329	)		43.23
Outstanding at December 31, 2013	2,516,618			$	39.6			6.87		$	86,200,655
Vested and expected to vest at December 31, 2013	2,400,548			$	39.23			6.78		$	83,095,331
Exercisable at December 31, 2013	1,086,636			$	32.47			5.05		$	44,963,329
The intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock as of the end of the period, and the grant price. The total intrinsic value of options exercised in 2013, 2012 and 2011, was $34.3 million, $23.5 million and $21.9 million, respectively. In 2013, 2012 and 2011, cash received from options exercised was $35.3 million, $45.8 million and $33.1 million, respectively, while the actual tax benefit realized for the tax deductions from stock options exercised totaled $12.5 million, $8.6 million and $8.0 million, respectively.
A summary of the Company’s unvested share activity as of December 31, 2013, and changes during the year ending December 31, 2013 is presented in the following table:
Unvested Shares	Shares			Weighted-Average
				Grant Date Fair
				Value
Nonvested at January 1, 2013	589,986			$	40.27
Granted	232,418			56.2
Vested	(154,795	)		38.5
Forfeited	(48,930	)		53.58
Nonvested at December 31, 2013	618,679			$	40.27
Unvested share grants accrue dividends and their fair value is equal to the market price of the Company’s stock at the date of the grant.
A summary of the Company's performance share unit activity as of December 31, 2013, and changes during the year ending December 31, 2013 is presented in the following table:
Performance Share Units	Shares			Weighted-Average
				Grant Date Fair
				Value
Nonvested at January 1, 2013	—			$	—
Granted	54,065			59.58
Vested	—			—
Forfeited	(860	)		59.58
Nonvested at December 31, 2013	53,205			$	59.58
The Company also maintains a cash-settled share based compensation plan for certain employees. Total expense related to this plan was $3.6 million, $2.3 million and $0.8 million in 2013, 2012 and 2011 respectively. At December 31, 2013 and 2012, the Company has $2.0 million and $2.0 million, respectively, included in Accrued expenses in the Consolidated Balance Sheets and $1.0 million included in Other non-current liabilities at December 31, 2013.

Other_Comprehensive_Income_Los

Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Other Comprehensive Income (Loss)	'
	Other Comprehensive Income (Loss)
	The components of other comprehensive income (loss) are as follows:
		For the Year Ended December 31, 2013												For the Year Ended December 31, 2012
		Pre-tax				Tax				Net of tax				Pre-tax				Tax			Net of tax
		(In thousands)
	Cumulative translation adjustment	$	13,572			$	—			$	13,572			$	14,445			$	—		$	14,445
	Pension and other postretirement adjustments
	Net gain (loss) arising during the year	26,274				(9,859		)		16,415				(16,607		)		3,107			(13,500		)
	Amortization/settlement recognition of net loss (gain)	8,599				(3,226		)		5,373				7,801				(1,460		)	6,341
	Pension and other postretirement adjustments, net	34,873				(13,085		)		21,788				(8,806		)		1,647			(7,159		)
	Reclassification adjustments for derivatives	7,430				(2,692		)		4,738				7,571				(2,791		)	4,780
	Total other comprehensive income (loss)	$	55,875			$	(15,777	)		$	40,098			$	13,210			$	(1,144	)	$	12,066
								For the Year Ended December 31, 2011
								Pre-tax				Tax				Net of tax
								(In thousands)
	Cumulative translation adjustment							$	(14,108	)		$	—			$	(14,108	)
	Pension and other postretirement adjustments
	Net gain (loss) arising during the year							(18,066		)		6,038				(12,028		)
	Amortization or settlement recognition of net loss (gain)							5,446				(1,816		)		3,630
	Pension and other postretirement adjustments, net							(12,620		)		4,222				(8,398		)
	Reclassification adjustments for derivatives							(32,754		)		12,500				(20,254		)
	Total other comprehensive income (loss)							$	(59,482	)		$	16,722			$	(42,760	)
	Amounts reclassified from accumulated other comprehensive income (loss) to net income (loss) are summarized as follows:
			For the Years Ended December 31,
			2013				2012				2011				Income Statement Caption
	Pension and other postretirement plans:
	Amortization of service cost		$	8,599			$	7,801			$	5,446			Selling, general and administrative expense
	Total before tax		8,599				7,801				5,446
	Provision for income taxes		(3,226		)		(1,460		)		(1,816		)
	Total net of tax		$	5,373			$	6,341			$	3,630
	Derivatives:
	Reclassification adjustments		$	7,430			$	7,571			$	(32,754	)		Interest expense
	Total before tax		7,430				7,571				(32,754		)
	Provision for income taxes		(2,692		)		(2,791		)		12,500
	Total net of tax		$	4,738			$	4,780			$	(20,254	)

Retirement_Benefits

Retirement Benefits	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Retirement Benefits	'
	Retirement Benefits
	The Company sponsors several qualified and nonqualified pension plans and other postretirement plans for its employees. The Company uses a measurement date of December 31 for its defined benefit pension plans and post retirement medical plans. The Company employs the measurement date provisions of ASC 715, “Compensation-Retirement Benefits”, which require the measurement date of plan assets and liabilities to coincide with the sponsor’s year end.
	The following table provides a reconciliation of the changes in the benefit obligations and fair value of plan assets over the two-year period ended December 31, 2013, and a statement of the funded status at December 31 for both years.
		Pension Benefits															Other Benefits
		2013								2012							2013			2012
		U.S.				Non-U.S.				U.S.			Non-U.S.
		(In thousands)
	CHANGE IN BENEFIT OBLIGATION
	Obligation at January 1	$	111,188			$	56,555			$	101,511		$	47,763			$	25,587		$	21,073
	Service cost	1,526				1,388				1,756			1,300				968			763
	Interest cost	3,766				2,146				4,247			2,206				906			922
	Plan amendments	—				—				59			410				—			159
	Benefits paid	(2,479		)		(1,957		)		(4,097		)	(3,536		)		(801		)	(704		)
	Actuarial loss (gain)	(11,885		)		581				13,202			6,700				(5,139		)	3,313
	Currency translation	—				1,758				—			1,712				(167		)	61
	Curtailments/settlements	(9,277		)		—				(5,490		)	—				—			—
	Acquisition	—				—				—			—				—			—
	Obligation at December 31	$	92,839			$	60,471			$	111,188		$	56,555			$	21,354		$	25,587
	CHANGE IN PLAN ASSETS
	Fair value of plan assets at January 1	$	74,578			$	19,660			$	59,619		$	16,914			$	—		$	—
	Actual return on plan assets	14,303				2,341				6,177			1,944				—			—
	Employer contributions(1)	4,832				1,840				17,287			3,514				801			704
	Benefits paid	(2,479		)		(1,957		)		(4,097		)	(3,536		)		(801		)	(704		)
	Currency translation	—				447				—			810				—			—
	Settlements	(9,277		)		3				(4,408		)	—				—			—
	Other	—				—				—			14				—			—
	Fair value of plan assets at December 31	$	81,957			$	22,334			$	74,578		$	19,660			$	—		$	—
	Funded status at December 31	$	(10,882	)		$	(38,138	)		$	(36,610	)	$	(36,894	)		$	(21,354	)	$	(25,587	)
	COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS
	Current liabilities	$	(656	)		$	(995	)		$	(588	)	$	(743	)		$	(946	)	$	(907	)
	Other noncurrent liabilities	(10,226		)		(37,143		)		(36,022		)	(36,151		)		(20,408		)	(24,680		)
	Net liability at December 31	$	(10,882	)		$	(38,138	)		$	(36,610	)	$	(36,894	)		$	(21,354	)	$	(25,587	)
	-1	Includes $10.0 million discretionary contribution to U.S. plan in 2012.
	The accumulated benefit obligation (ABO) for all defined benefit pension plans was $143.5 million and $160.7 million at December 31, 2013 and 2012, respectively.
	The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2013 and 2012 were as follows:
		U.S. Plans						Non-U.S.
								Plans
		2013			2012			2013			2012
	Discount rate	4.61	%		3.56	%		4.03	%		3.91	%
	Rate of compensation increase	4	%		3.94	%		3.14	%		2.99	%
	The pretax amounts recognized in Accumulated other comprehensive income (loss) as of December 31, 2013 and 2012 were as follows:
		Pension Benefits															Other Benefits
		2013								2012							2013			2012
		U.S.				Non-U.S.				U.S.			Non-U.S
		(In thousands)
	Prior service cost (credit)	$	170			$	312			$	275		$	330			$	(1,951	)	$	(2,325	)
	Net loss	22,854				14,262				51,240			15,496				(225		)	5,279
	Total	$	23,024			$	14,574			$	51,515		$	15,826			$	(2,176	)	$	2,954
	The amounts in Accumulated other comprehensive income (loss) as of December 31, 2013, that are expected to be recognized as components of net periodic benefit cost during 2014 are as follows:
		U.S. Pension				Non-U.S.				Other			Total
		Benefit Plans				Pension Benefit				Benefit Plans
						Plans
		(In thousands)
	Prior service cost (credit)	$	84			$	26			$	(371	)	$	(261	)
	Net loss	2,306				851				(105		)	3,052
	Total	$	2,390			$	877			$	(476	)	$	2,791
	The following tables provide the components of, and the weighted average assumptions used to determine, the net periodic benefit cost for the plans in 2013, 2012 and 2011:
		Pension Benefits
		2013								2012							2011
		U.S.				Non-U.S.				U.S.			Non-U.S.				U.S.			Non-U.S.
		(In thousands)
	Service cost	$	1,526			$	1,388			$	1,756		$	1,300			$	1,759		$	1,078
	Interest cost	3,766				2,146				4,247			2,206				4,506			2,320
Expected return on plan assets	(5,318		)		(1,055		)		(4,687		)	(1,035		)		(4,755		)	(1,117		)
Net amortization	7,621				955				5,376			589				4,855			442
Net periodic benefit cost	$	7,595			$	3,434			$	6,692		$	3,060			$	6,365		$	2,723
	Other Benefits
	2013				2012				2011
	(In thousands)
Service cost	$	968			$	763			$	691
Interest cost	906				922				1,035
Net amortization	24				11				(156		)
Net periodic benefit cost	$	1,898			$	1,696			$	1,570
	U.S. Plans									Non-U.S. Plans
	2013			2012			2011			2013		2012			2011
Discount rate	3.56	%		4.45	%		5.2	%		3.91	%	4.68	%		5.35	%
Expected return on plan assets	7.5	%		8	%		8.25	%		5.53	%	5.9	%		6.17	%
Rate of compensation increase	3.94	%		3.9	%		3.9	%		2.99	%	2.96	%		3.37	%
The following table provides the pretax change recognized in Accumulated other comprehensive income (loss) in 2013:
	Pension Benefits
	U.S.				Non-U.S.				Other
									Benefits
	(In thousands)
Net loss in current year	$	20,869			$	708			$	5,140
Prior service cost	—				—				—
Amortization of prior service cost (credit)	104				25				(373		)
Amortization of net loss	7,518				929				396
Exchange rate effect on amounts in OCI	—				(410		)		(33		)
Total	$	28,491			$	1,252			$	5,130
The discount rates for our plans are derived by matching the plan’s cash flows to a yield curve that provides the equivalent yields on zero-coupon bonds for each maturity. The discount rate selected is the rate that produces the same present value of cash flows.
In selecting the expected rate of return on plan assets, the Company considers the historical returns and expected returns on plan assets. The expected returns are evaluated using asset return class, variance and correlation assumptions based on the plan’s target asset allocation and current market conditions.
Prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10% of the greater of the benefit obligation or the market value of assets are amortized over the average remaining service period of active participants.
Costs of defined contribution plans were $8.4 million, $7.9 million and $7.8 million for 2013, 2012 and 2011, respectively.
The Company, through its subsidiaries, participates in certain multiemployer pension plans covering approximately 393 participants under U.S. collective bargaining agreements. None of these plans are considered individually significant to the Company as contributions to these plans totaled $1.1 million, $1.0 million, and $1.0 million for 2013, 2012 and 2011, respectively.
For measurement purposes, a 7.27% weighted average annual rate of increase in the per capita cost of covered health care benefits was assumed for 2013. The rate was assumed to decrease gradually each year to a rate of 4.49% for 2027, and remain at that level thereafter. Assumed health care cost trend rates have a significant effect on the amounts reported for the health care plans. A 1% increase in the assumed health care cost trend rates would increase the service and interest cost components of the net periodic benefit cost by $0.2 million and the health care component of the accumulated postretirement benefit obligation by $1.4 million. A 1% decrease in the assumed health care cost trend rate would decrease the service and interest cost components of the net periodic benefit cost by $0.2 million and the health care component of the accumulated postretirement benefit obligation by $1.2 million.
Plan Assets
The Company’s pension plan weighted average asset allocations at December 31, 2013 and 2012, by asset category, were as follows:
	2013			2012
Equity securities	66	%		68	%
Fixed income securities	34	%		32	%
Total	100	%		100	%
The following tables summarize the basis used to measure the defined benefit plans’ assets at fair value at December 31, 2013 and 2012:
	Basis of Fair Value Measurement
	Outstanding				Level 1				Level 2			Level 3
	Balances
As of December 31, 2013	(In thousands)
Equity
U.S. Large Cap	$	31,831			$	31,831			$	—		$	—
U.S. Small / Mid Cap	8,783				8,783				—			—
International	25,591				25,591				—			—
Fixed Income
U.S. Intermediate	18,715				18,715				—			—
U.S. Short Duration	8,954				8,954				—			—
U.S. High Yield	1,581				1,581				—			—
International	5,812				5,812				—			—
Other
Insurance Contracts	331				—				331			—
Cash and Equivalents	2,693				2,693				—			—
	$	104,291			$	103,960			$	331		$	—
	Basis of Fair Value Measurement
	Outstanding				Level 1				Level 2			Level 3
	Balances
As of December 31, 2012	(In thousands)
Equity
U.S. Large Cap	$	32,496			$	32,496			$	—		$	—
U.S. Small / Mid Cap	7,770				7,770				—			—
International	20,869				13,082				7,787			—
Fixed Income
U.S. Intermediate	25,069				25,069				—			—
U.S. Short Duration	—				—				—			—
U.S. High Yield	—				—				—			—
International	5,489				5,489				—			—
Other
Insurance Contracts	326				326				—			—
Cash and Equivalents	2,219				2,219				—			—
	$	94,238			$	86,451			$	7,787		$	—
Equities that are valued using quoted prices are valued at the published market prices. Equities in a common collective trust or a registered investment company that are valued using significant other observable inputs are valued at the net asset value (“NAV”) provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund minus its liabilities. Fixed income securities that are valued using significant other observable inputs are valued at prices obtained from independent financial service industry-recognized vendors.
Investment Policies and Strategies
The investment objectives of the Company’s plan assets are to earn the highest possible rate of return consistent with the tolerance for risk as determined periodically by the Company in its role as a fiduciary. The general guidelines of asset allocation of fund assets are that “equities” will represent from 50% to 60% of the market value of total fund assets with a target of 50% by June 30, 2015, and “fixed income” obligations, including cash, will represent from 40% to 50% with a target of 50% by June 30, 2015. The term “equities” includes common stock, convertible bonds and convertible stock. The term “fixed income” includes preferred stock and/or contractual payments with a specific maturity date. The Company strives to maintain asset allocations within the designated ranges by conducting periodic reviews of fund allocations and plan liquidity needs, and rebalancing the portfolio accordingly. The total fund performance is monitored and results measured using a 3- to 5-year moving average against long-term absolute and relative return objectives to meet actuarially determined forecasted benefit obligations. No restrictions are placed on the selection of individual investments by the qualified investment fund managers. The performance of the investment fund managers is reviewed on a regular basis, using appointed professional independent advisors. As of December 31, 2013 and 2012, there were no shares of the Company’s stock held in plan assets.
Cash Flows
The Company expects to contribute approximately $2.8 million to its defined benefit plans and $0.9 million to its other postretirement benefit plans in 2014. The Company also expects to contribute approximately $8.4 million to its defined contribution plan and $7.3 million to its 401(k) savings plan in 2014.
Estimated Future Benefit Payments
The future estimated benefit payments for the next five years and the five years thereafter are as follows: 2014 — $9.1 million; 2015 — $8.5 million; 2016 — $9.0 million; 2017 — $9.4 million; 2018 — $9.9 million; 2019 to 2023 — $53.0 million

Quarterly_Results_of_Operation

Quarterly Results of Operations (Unaudited)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Results of Operations (Unaudited)	'
	Quarterly Results of Operations (Unaudited)
	The following table summarizes the unaudited quarterly results of operations for the years ended December 31, 2013 and 2012.
		2013 Quarters								2012 Quarters
		First		Second		Third		Fourth		First		Second		Third		Fourth(1)
		(In thousands, except per share amounts)
	Net sales	$	494,448	$	518,445	$	490,617	$	520,620	$	489,417	$	494,144	$	479,859	$	490,838
	Gross profit	211,997		222,849		211,509		227,009		202,889		203,113		194,840		202,858
	Operating income (loss)	94,712		99,559		97,369		103,873		84,569		88,650		80,588		(125,589		)
	Net income (loss)	61,300		62,561		63,799		67,555		52,171		54,351		50,127		(119,019		)
	Basic EPS	$	0.74	$	0.76	$	0.78	$	0.83	$	0.63	$	0.65	$	0.6	$	(1.45	)
	Diluted EPS	$	0.74	$	0.76	$	0.78	$	0.82	$	0.62	$	0.65	$	0.6	$	(1.45	)
	Basic weighted average shares outstanding	82,197		81,829		81,259		80,782		82,804		83,180		82,482		82,296
	Diluted weighted average shares outstanding	83,152		82,734		82,218		81,854		83,902		84,090		83,370		82,296
	-1	Fourth quarter 2012 includes a $198.5 million asset impairment charge.

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Business	'
	Business
	IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to its customers’ specifications. IDEX's products are sold in niche markets to a wide range of industries throughout the world. The Company’s products include industrial pumps, compressors, flow meters, injectors and valves, and related controls for use in a wide variety of process applications; precision fluidics solutions, including pumps, valves, degassing equipment, corrective tubing, fittings, and complex manifolds, precision photonic solutions, optical filters and specialty medical equipment and devices used in life science applications; precision-engineered equipment for dispensing, metering and mixing paints; refinishing equipment; and engineered products for industrial and commercial markets, including fire and rescue, transportation equipment, oil and gas, electronics, and communications. These activities are grouped into three reportable segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products.
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for doubtful accounts, inventory valuation, recoverability of long-lived assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable, and collectability of the sales price is reasonably assured. For product sales, delivery does not occur until the products have been shipped and risk of loss has been transferred to the customer. Revenue from services is recognized when the services are provided or ratably over the contract term. Some arrangements with customers may include multiple deliverables, including the combination of products and services. In such cases the Company has identified these as separate elements in accordance with ASC 605-25 and recognizes revenue consistent with the policy for each separate element based on the relative selling price method. Revenues from certain long-term contracts are recognized on the percentage-of-completion method. Percentage-of-completion is measured principally by the percentage of costs incurred to date for each contract to the estimated total costs for such contract at completion. Provisions for estimated losses on uncompleted long-term contracts are made in the period in which such losses are determined. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised in the near-term. Such revisions to costs and income are recognized in the period in which the revisions are determined.
	The Company records allowances for discounts, product returns and customer incentives at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company.
Shipping and Handling Costs	'
	Shipping and Handling Costs
	Shipping and handling costs are included in cost of sales and are recognized as a period expense during the period in which they are incurred.
Advertising Costs	'
	Advertising Costs
	Advertising costs of $14.6 million, $15.3 million and $13.4 million for 2013, 2012 and 2011, respectively, are expensed as incurred within Selling, general and administrative expenses.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments purchased with an original maturity of 90 days or less to be cash and cash equivalents.
Allowance for Doubtful Accounts	'
	Allowance for Doubtful Accounts
	The Company maintains allowances for doubtful accounts for estimated losses as a result of customer’s inability to make required payments. Management evaluates the aging of the accounts receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of accounts receivables that may not be collected in the future and records the appropriate provision.
Inventories	'
	Inventories
	The Company states inventories at the lower of cost or market. Cost, which includes material, labor, and factory overhead, is determined on a FIFO basis. We make adjustments to reduce the cost of inventory to its net realizable value, if required, at the business unit level for estimated excess, obsolescence or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	Long-lived assets are reviewed for impairment upon the occurrence of events or changes in circumstances that indicate that the carrying value of the assets may not be recoverable, as measured by comparing their net book value to the projected undiscounted future cash flows generated by their use. Impaired assets are recorded at their estimated fair value based on a discounted cash flow analysis.
Goodwill and Indefinite-Lived Intangible Assets	'
	Goodwill and Indefinite-Lived Intangible Assets
	In accordance with ASC 350, the Company reviews the carrying value of goodwill and indefinite-lived intangible assets annually on October 31, or upon the occurrence of events or changes in circumstances that indicate that the carrying value of the goodwill or intangible assets may not be recoverable. The Company evaluates the recoverability of these assets based on the estimated fair value of each of the fifteen reporting units and the indefinite-lived intangible asset. See Note 4 for a further discussion on goodwill and intangible assets.
Borrowing Expenses	'
	Borrowing Expenses
	Expenses incurred in securing and issuing debt are capitalized and included in Other noncurrent assets. These assets are amortized over the life of the related borrowing and the related amortization is included in Interest expense in the Consolidated Statements of Operations.
Earnings per Common Share	'
	Earnings per Common Share
	Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of shares of common stock (basic) plus common stock equivalents (diluted) outstanding during the year. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, unvested shares, performance share units, and shares issuable in connection with certain deferred compensation agreements ("DCUs").
	ASC 260 concludes that all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding unvested shares are participating securities. Accordingly, earnings per common share were computed using the two-class method prescribed by ASC 260. Net income attributable to common shareholders was reduced by $1.2 million, $0.1 million and $1.2 million in 2013, 2012 and 2011, respectively.
	Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows:
		2013	2012	2011
		(In thousands)
	Basic weighted average common shares outstanding	81,517	82,689	82,145
	Dilutive effect of stock options, unvested shares, performance share units and DCUs	972	952	1,398
	Diluted weighted average common shares outstanding	82,489	83,641	83,543
	Options to purchase approximately zero, 1.2 million and 0.7 million shares of common stock in 2013, 2012 and 2011, respectively, were not included in the computation of diluted EPS because the effect of their inclusion would have been antidilutive.
Share-Based Compensation	'
	Share-Based Compensation
	The Company accounts for share-based payments in accordance with ASC 718. Accordingly, the Company expenses the fair value of awards made under its share-based compensation plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants. See Note 13 for further discussion on share-based compensation.
Depreciation and Amortization	'
	Depreciation and Amortization
	Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives:
	Land improvements	8 to 12 years
	Buildings and improvements	8 to 30 years
	Machinery, equipment and other	3 to 12 years
	Office and transportation equipment	3 to 10 years
	Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows:
	Patents	5 to 17 years
	Trade names	10 to 20 years
	Customer relationships	4.5 to 20 years
	Non-compete agreements	2.5 to 3 years
	Unpatented technology and other	4.5 to 20 years
Research and Development Expenditures	'
	Research and Development Expenditures
	Costs associated with research and development are expensed in the period incurred and are included in Cost of sales within the Consolidated Statements of Operations. Research and development expenses, which include costs associated with developing new products and major improvements to existing products, were $33.0 million, $36.4 million and $36.0 million in 2013, 2012 and 2011, respectively.
Foreign Currency Translation	'
	Foreign Currency Translation
	The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date. Income statement amounts have been translated using the average exchange rate for the year. The gains and losses resulting from changes in exchange rates from year to year have been reported in Accumulated other comprehensive loss in the Consolidated Balance Sheets. The effect of transaction gains and losses is reported within Other income (expense)-net in the Consolidated Statements of Operations.
Income Taxes	'
	Income Taxes
	Income tax expense includes United States, state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and the tax basis of existing assets and liabilities and for loss carryforwards. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized.
Concentration of Credit Risk	'
	Concentration of Credit Risk
	The Company is not dependent on a single customer, the largest of which accounted for less than 2% of net sales for all years presented.
Recently Adopted Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-02 which requires additional disclosures regarding the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-02 requires an entity to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. This guidance is effective for reporting periods beginning after December 15, 2012. The Company adopted this guidance effective January 1, 2013 and its adoption did not impact the consolidated financial position, results of operations or cash flows of the Company. See Note 14 for a further discussion on other comprehensive income (loss).

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule Of Basic Weighted Average Shares Reconciles To Diluted Weighted Average Shares	'
	Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows:
		2013	2012	2011
		(In thousands)
	Basic weighted average common shares outstanding	81,517	82,689	82,145
	Dilutive effect of stock options, unvested shares, performance share units and DCUs	972	952	1,398
	Diluted weighted average common shares outstanding	82,489	83,641	83,543
Property And Equipment At Cost, Depreciation And Amortization Estimated Useful Lives	'
	Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives:
	Land improvements	8 to 12 years
	Buildings and improvements	8 to 30 years
	Machinery, equipment and other	3 to 12 years
	Office and transportation equipment	3 to 10 years
Schedule of Identifiable Intangible Assets, Useful Lives	'
	Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows:
	Patents	5 to 17 years
	Trade names	10 to 20 years
	Customer relationships	4.5 to 20 years
	Non-compete agreements	2.5 to 3 years
	Unpatented technology and other	4.5 to 20 years

Restructuring_Tables

Restructuring (Tables)	12 Months Ended
	Dec. 31, 2013
Restructuring and Related Activities [Abstract]	'
Schedule of Pre-Tax Restructuring Expenses By Segment	'
	Pre-tax restructuring expenses by segment, for 2012, were as follows:
		Severance			Exit Costs		Total
		Costs
		(In thousands)
	Fluid & Metering Technologies	$	6,226		$	36	$	6,262
	Health & Science Technologies	11,223			3,521		14,744
	Fire & Safety/Diversified Products	3,226			5,114		8,340
	Corporate/Other	2,844			283		3,127
	Total restructuring costs	$	23,519		$	8,954	$	32,473
	Pre-tax restructuring expenses by segment, for 2011, were as follows:
		Severance			Exit Costs		Total
		Costs
		(In thousands)
	Fluid & Metering Technologies	$	2,800		$	61	$	2,861
	Health & Science Technologies	2,007			123		2,130
	Fire & Safety/Diversified Products	4,430			797		5,227
	Corporate/Other	2,096			—		2,096
	Total restructuring costs	$	11,333		$	981	$	12,314
Schedule of Restructuring Accruals Expenses	'
	Restructuring accruals of $10.9 million at December 31, 2012 are reflected in Accrued expenses in our Consolidated Balance Sheets as follows:
		2011
		Initiative
		(In thousands)
	Balance at January 1, 2012	$	5,875
	Restructuring expenses	32,473
	Payments, utilization and other	(27,461		)
	Balance at December 31, 2012	10,887
	Restructuring expenses	—
	Payments, utilization and other	(10,887		)
	Balance at December 31, 2013	$	—

Balance_Sheet_Components_Table

Balance Sheet Components (Tables)	12 Months Ended
	Dec. 31, 2013
Additional Financial Information Disclosure [Abstract]	'
Balance Sheet Components	'
		December 31,
		2013			2012
		(In thousands)
	RECEIVABLES
	Customers	$	255,992		$	257,114
	Other	3,075			4,577
	Total	259,067			261,691
	Less allowance for doubtful accounts	5,841			5,596
	Total receivables — net	$	253,226		$	256,095
	INVENTORIES
	Raw materials and components parts	$	133,470		$	139,229
	Work in process	41,895			33,025
	Finished goods	55,602			62,696
	Total	$	230,967		$	234,950
	PROPERTY, PLANT AND EQUIPMENT
	Land and improvements	$	32,723		$	31,787
	Buildings and improvements	150,316			141,952
	Machinery, equipment and other	300,858			288,542
	Office and transportation equipment	95,923			95,920
	Construction in progress	9,201			12,040
	Total	589,021			570,241
	Less accumulated depreciation and amortization	375,533			351,080
	Total property, plant and equipment — net	$	213,488		$	219,161
	ACCRUED EXPENSES
	Payroll and related items	$	63,297		$	55,618
	Management incentive compensation	20,949			15,974
	Income taxes payable	11,746			10,284
	Insurance	7,741			8,974
	Warranty	4,888			4,875
	Deferred revenue	9,455			9,682
	Restructuring	—			10,887
	Liability for uncertain tax positions	1,201			2,679
	Accrued interest	1,354			1,713
	Contingent consideration for acquisition	—			3,528
	Other	30,120			25,962
	Total accrued expenses	$	150,751		$	150,176
	OTHER NONCURRENT LIABILITIES
	Pension and retiree medical obligations	$	67,777		$	96,853
	Liability for uncertain tax positions	4,624			4,989
	Deferred revenue	5,578			6,534
	Contingent consideration for acquisition	—			5,515
	Other	15,087			14,484
	Total other noncurrent liabilities	$	93,066		$	128,375
Valuation and Qualifying Accounts	'
		2013			2012			2011
		(In thousands)
	VALUATION AND QUALIFYING ACCOUNTS(1)
	Beginning balance January 1	$	5,596		$	5,860		$	5,322
	Charged to costs and expenses, net of recoveries	2,288			653			1,044
	Utilization	(1,921		)	(1,151		)	(917		)
	Currency translation and other	(122		)	234			411
	Ending balance December 31	$	5,841		$	5,596		$	5,860
	-1	Includes provision for doubtful accounts, sales returns and sales discounts granted to customers.

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Changes in the Carrying Amount of Goodwill	'
	The changes in the carrying amount of goodwill for 2013 and 2012, by business segment, were as follows:
		Fluid &			Health &			Fire &  Safety/			Total
		Metering			Science			Diversified
		Technologies			Technologies			Products
		(In thousands)
	Goodwill	$	541,640		$	648,906		$	270,910		$	1,461,456
	Accumulated impairment losses	—			—			(30,090		)	(30,090		)
	Balance at January 1, 2012	541,640			648,906			240,820			1,431,366
	Acquisition adjustments	—			1,424			—			1,424
	Acquisitions (Note 12)	—			50,387			—			50,387
	Foreign currency translation	3,406			2,307			3,378			9,091
	Goodwill impairment	(20,721		)	(149,820		)	—			(170,541		)
	Balance at December 31, 2012	524,325			553,204			244,198			1,321,727
	Acquisitions (Note 12)	—			17,994			—			17,994
	Foreign currency translation	3,719			477			5,539			9,735
	Balance at December 31, 2013	$	528,044		$	571,675		$	249,737		$	1,349,456
Schedule of Gross Carrying Value and Accumulated Amortization For Each Major Class of Intangible Asset	'
	The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2013 and 2012:
		At December 31, 2013											At December 31, 2012
		Gross			Accumulated			Net			Weighted		Gross		Accumulated			Net
		Carrying			Amortization						Average		Carrying		Amortization
		Amount									Life		Amount
					(In thousands)										(In thousands)
	Amortizable intangible assets:
	Patents	$	10,673		$	(5,179	)	$	5,494		11		$	10,650	$	(4,273	)	$	6,377
	Trade names	104,582			(28,310		)	76,272			16		103,113		(21,603		)	81,510
	Customer relationships	242,674			(121,092		)	121,582			10		230,196		(93,273		)	136,923
	Non-compete agreements	3,769			(3,272		)	497			3		3,505		(2,827		)	678
	Unpatented technology	75,528			(32,905		)	42,623			11		74,758		(24,211		)	50,547
	Other	6,958			(4,299		)	2,659			10		6,841		(3,604		)	3,237
	Total amortizable intangible assets	444,184			(195,057		)	249,127					429,063		(149,791		)	279,272
	Unamortized intangible assets:
	Banjo trade name	62,100			—			62,100					62,100		—			62,100
	Total intangible assets	$	506,284		$	(195,057	)	$	311,227				$	491,163	$	(149,791	)	$	341,372

Borrowings_Tables

Borrowings (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Borrowings	'
	Borrowings at December 31, 2013 and 2012 consisted of the following:
		2013		2012
		(In thousands)
	Revolving Facility	$	10,000	$	21,000
	4.2% Senior Notes, due December 2021	349,272		349,197
	4.5% Senior Notes, due December 2020	298,828		298,689
	2.58% Senior Euro Notes, due June 2015	111,505		107,042
	Other borrowings	4,271		10,648
	Total borrowings	773,876		786,576
	Less current portion	1,871		7,335
	Total long-term borrowings	$	772,005	$	779,241
Schedule of Maturities of Borrowings	'
	Total borrowings at December 31, 2013 have scheduled maturities as follows (in thousands):
	2014	$	1,871
	2015	112,085
	2016	10,530
	2017	1,190
	2018	100
	Thereafter	648,100
	Total borrowings	$	773,876

Derivative_Instruments_Tables

Derivative Instruments (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Summary of Gain (Loss) Recognized and Amounts and Location of Income (Expense) and Gain (Loss) Reclassified Into Income For Interest Rate Contracts and Foreign Currency Contracts	'
	The following table summarizes the gain (loss) recognized and the amounts and location of income (expense) and gain (loss) reclassified into income for interest rate contracts and foreign currency contracts for the year ended December 31, 2013 and 2012:
		Loss Recognized in						Income (Expense)									Income
		Other  Comprehensive Income						and Gain (Loss)									Statement
								Reclassified into Income									Caption
		Twelve Months Ended December 31,
		2013		2012		2011		2013			2012			2011
		(In thousands)
	Interest rate agreements	$	—	$	—	$	—	$	(7,430	)	$	(7,637	)	$	(3,570	)	Interest expense

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Schedule of Company's Financial Assets and (Liabilities) at Fair Value on Recurring Basis	'
	The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheet at December 31, 2013 and 2012:
		Basis of Fair Value Measurements
		Balance at December 31, 2013			Level 1		Level 2		Level 3
		(In thousands)
	Money market investments	$	27,871		$	27,871	$	—	$	—
	Available for sale securities	3,255			3,255		—		—
		Balance at December 31, 2012			Level 1		Level 2		Level 3
		(In thousands)
	Money market investments	$	11,165		$	11,165	$	—	$	—
	Available for sale securities	2,862			2,862		—		—
	Contingent consideration	(9,043		)	—		—		(9,043		)

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Future Minimum Lease Payments For Operating and Capital Leases	'
	The aggregate future minimum lease payments for operating and capital leases as of December 31, 2013 were as follows:
		Operating			Capital
		(In thousands)
	2014	$	15,426		$	564
	2015	11,811			604
	2016	7,742			548
	2017	5,177			1,192
	2018	3,964			100
	2019 and thereafter	5,945			—
		$	50,065		$	3,008
Roll Forward of the Warranty Reserve	'
	A rollforward of the warranty reserve is as follows:
		2013			2012			2011
		(In thousands)
	Beginning balance January 1st	$	4,875		$	4,417		$	3,831
	Provision for warranties	3,845			5,398			4,648
	Claim settlements	(3,865		)	(5,214		)	(4,443		)
	Other adjustments, including acquisitions and currency translation	33			274			381
	Ending balance December 31st	$	4,888		$	4,875		$	4,417

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Income Before Income Tax	'
	Pretax income for 2013, 2012 and 2011 was taxed in the following jurisdictions:
		2013			2012			2011
		(In thousands)
	Domestic	$	233,530		$	65,738		$	192,857
	Foreign	119,599			20,466			81,024
	Total	$	353,129		$	86,204		$	273,881
Schedule of Components of Income Tax	'
	The provision (benefit) for income taxes for 2013, 2012 and 2011, was as follows:
		2013			2012			2011
		(In thousands)
	Current
	U.S.	$	59,707		$	59,811		$	48,823
	State and local	8,123			5,764			3,434
	Foreign	33,240			20,228			31,343
	Total current	101,070			85,803			83,600
	Deferred
	U.S.	1,500			(31,246		)	4,792
	State and local	(55		)	(2,377		)	(1,103		)
	Foreign	(4,601		)	(3,606		)	(7,265		)
	Total deferred	(3,156		)	(37,229		)	(3,576		)
	Total provision for income taxes	$	97,914		$	48,574		$	80,024
Schedule of Deferred Tax Assets and Liabilities	'
	Deferred tax assets (liabilities) at December 31, 2013 and 2012 were:
		2013			2012
		(In thousands)
	Employee and retiree benefit plans	$	27,361		$	38,401
	Depreciation and amortization	(175,894		)	(170,630		)
	Inventories	9,627			10,851
	Allowances and accruals	9,632			7,629
	Interest rate exchange agreement	18,165			20,856
	Other	4,636			7,059
	Total	$	(106,473	)	$	(85,834	)
Schedule of Deferred Tax Assets (Liabilities) Recognized In Balance Sheets	'
	The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2013 and 2012 were:
		2013			2012
		(In thousands)
	Deferred tax asset — other current assets	$	34,151		$	32,293
	Deferred tax asset — other noncurrent assets	4,284			3,222
	Total deferred tax assets	38,435			35,515
	Deferred tax liability — accrued expenses	—			—
	Noncurrent deferred tax liability — deferred income taxes	(144,908		)	(121,349		)
	Total deferred tax liabilities	(144,908		)	(121,349		)
	Net deferred tax liabilities	$	(106,473	)	$	(85,834	)
Schedule of Effective Income Tax Rate Reconciliation	'
	The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate to pretax income. The computed amount and the differences for 2013, 2012 and 2011 are shown in the following table:
		2013			2012			2011
		(In thousands)
	Pretax income	$	353,129		$	86,204		$	273,881
	Provision for income taxes:
	Computed amount at statutory rate of 35%	$	123,595		$	30,171		$	95,858
	State and local income tax (net of federal tax benefit)	4,382			2,406			1,515
	Taxes on non-U.S. earnings-net of foreign tax credits	(9,683		)	1,189			(4,522		)
	Effect of flow-through entities	(7,267		)	(7,846		)	(6,922		)
	Asset impairments	—			28,524			—
	U.S. business tax credits	(1,516		)	—			(917		)
	Domestic activities production deduction	(6,217		)	(5,267		)	(4,589		)
	Other	(5,380		)	(603		)	(399		)
	Total provision for income taxes	$	97,914		$	48,574		$	80,024
Schedule of Unrecognized Tax Benefits	'
	A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2013, 2012 and 2011 are shown in the following table:
		2013			2012			2011
		(In thousands)
	Beginning balance January 1st	$	6,506		$	5,548		$	6,440
	Gross increases for tax positions of prior years	1,357			3,017			1,828
	Gross decreases for tax positions of prior years	(99		)	(98		)	(1,595		)
	Settlements	(1,219		)	—			(338		)
	Lapse of statute of limitations	(1,421		)	(1,961		)	(787		)
	Ending balance December 31st	$	5,124		$	6,506		$	5,548

Business_Segments_and_Geograph1

Business Segments and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Schedule of Information On Company's Business Segments	'
		2013			2012			2011
		(In thousands)
	NET SALES
	Fluid & Metering Technologies
	External customers	$	870,720		$	829,320		$	830,821
	Intersegment sales	1,094			3,968			466
	Total segment sales	871,814			833,288			831,287
	Health & Science Technologies
	External customers	708,940			689,574			606,247
	Intersegment sales	5,710			5,661			1,653
	Total segment sales	714,650			695,235			607,900
	Fire & Safety/Diversified Products
	External customers	444,470			435,364			401,383
	Intersegment sales	579			1,689			1,042
	Total segment sales	445,049			437,053			402,425
	Intersegment eliminations	(7,383		)	(11,318		)	(3,161		)
	Total net sales	$	2,024,130		$	1,954,258		$	1,838,451
	OPERATING INCOME (LOSS)(1)
	Fluid & Metering Technologies(2)	$	211,256		$	146,650		$	164,818
	Health & Science Technologies(2)	136,707			(62,835		)	106,037
	Fire & Safety/Diversified Products	102,730			96,120			85,901
	Corporate office	(55,180		)	(51,717		)	(52,100		)
	Total operating income	395,513			128,218			304,656
	Interest expense	42,206			42,250			29,332
	Other income (expense) - net	(178		)	236			(1,443		)
	Income before taxes	$	353,129		$	86,204		$	273,881
		2013			2012			2011
		(In thousands)
	ASSETS
	Fluid & Metering Technologies	$	1,025,352		$	1,023,143		$	1,072,023
	Health & Science Technologies	1,113,546			1,102,868			1,178,653
	Fire & Safety/Diversified Products	484,139			488,886			442,400
	Corporate office	264,540			170,493			143,031
	Total assets	$	2,887,577		$	2,785,390		$	2,836,107
	DEPRECIATION AND AMORTIZATION(3)
	Fluid & Metering Technologies	$	27,633		$	29,637		$	32,368
	Health & Science Technologies	43,496			39,981			30,055
	Fire & Safety/Diversified Products	6,852			7,107			8,516
	Corporate office and other	1,353			1,587			1,447
	Total depreciation and amortization	$	79,334		$	78,312		$	72,386
	CAPITAL EXPENDITURES
	Fluid & Metering Technologies	$	11,581		$	13,535		$	12,543
	Health & Science Technologies	12,280			13,140			12,938
	Fire & Safety/Diversified Products	5,040			6,654			5,644
	Corporate office and other	2,635			2,191			3,423
	Total capital expenditures	$	31,536		$	35,520		$	34,548
	-1	Segment operating income excludes net unallocated corporate operating expenses.
	-2	Segment operating income includes asset impairment charges in 2012 of $27.7 million within the Fluid & Metering Technologies segment and $170.8 million within the Health & Science Technologies segment.
	-3	Excludes amortization of debt issuance expenses.
Schedule of Sales From External Customers and Long-Lived Assets	'
	Information about the Company’s operations in different geographical regions for the years ended December 31, 2013, 2012 and 2011 is shown below. Net sales were attributed to geographic areas based on location of the customer, and no country outside the U.S. was greater than 10% of total revenues.
		2013			2012			2011
		(In thousands)
	NET SALES
	U.S.	$	983,791		$	963,137		$	857,990
	Europe	521,491			479,744			492,125
	Asia	306,466			305,185			278,900
	Other countries	212,382			206,192			209,436
	Total net sales	$	2,024,130		$	1,954,258		$	1,838,451
	LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT
	U.S.	$	124,880		$	127,425		$	124,102
	Europe	63,018			64,137			63,433
	Asia	24,590			26,320			24,570
	Other countries	1,000			1,279			1,612
	Total long-lived assets — net	$	213,488		$	219,161		$	213,717

Acquisitions_Tables

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Schedule of Allocation of Acquisition Costs To Assets Acquired and Liabilities Assumed	'
	The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values, is as follows:
	(In thousands)	ERC			PPC			Matcon			Total
	Accounts receivable	$	5,766		$	877		$	7,768		$	14,411
	Inventory	4,224			932			604			5,760
	Other current assets, net of cash acquired	981			252			1,880			3,113
	Property, plant and equipment	2,738			1,936			5,695			10,369
	Goodwill	8,499			13,941			27,947			50,387
	Intangible assets	5,642			5,104			14,081			24,827
	Other assets	1,509			13			53			1,575
	Total assets acquired	29,359			23,055			58,028			110,442
	Total liabilities assumed	(16,074		)	(2,465		)	(12,215		)	(30,754		)
	Net assets acquired	$	13,285		$	20,590		$	45,813		$	79,688
	The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values, is as follows:
	(In thousands)
	Accounts receivable	$	3,454
	Inventory	4,524
	Other current assets, net of cash acquired	131
	Property, plant and equipment	1,357
	Goodwill	17,994
	Intangible assets	13,016
	Total assets acquired	40,476
	Total liabilities assumed	(5,939		)
	Net assets acquired	$	34,537
	(In thousands)	AT Films			Microfluidics			CVI MG			Total
	Accounts receivable	$	947		$	1,760		$	23,978		$	26,685
	Inventory	852			2,226			52,868			55,946
	Other current assets, net of cash acquired	73			816			7,562			8,451
	Property, plant and equipment	5,019			567			31,049			36,635
	Goodwill	18,220			5,853			208,540			232,613
	Intangible assets	11,435			9,717			115,777			136,929
	Other assets	2,731			548			2,112			5,391
	Total assets acquired	39,277			21,487			441,886			502,650
	Total liabilities assumed	(4,766		)	(2,951		)	(48,572		)	(56,289		)
	Net assets acquired	$	34,511		$	18,536		$	393,314		$	446,361
Acquired Intangible Assets and Weighted Average Amortization Periods	'
	The acquired intangible assets and weighted average amortization periods are as follows:
	(In thousands, except weighted average life)	Total			Weighted
					Average
					Life
	Trade names	$	1,005		15
	Non-compete agreements	224			3
	Customer relationships	10,950			9
	Unpatented technology	837			8
	2013 acquired intangible assets	$	13,016
	(In thousands, except weighted average life)	Total			Weighted
					Average
					Life
	Patents	$	3,017		10
	Trade names	4,168			15
	Customer relationships	53,895			7
	Non-compete agreements	793			2
	Unpatented technology	28,048			6
	2011 acquired intangible assets	$	89,921
	The acquired intangible assets and weighted average amortization periods are as follows:
	(In thousands, except weighted average life)	Total			Weighted
					Average
					Life
	Trade names	$	8,973		15
	Non-compete agreements	470			3
	Customer relationships	11,343			6
	Unpatented technology	4,041			8
	2012 acquired intangible assets	$	24,827

ShareBased_Compensation_Tables

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Weighted Average Option Fair Values and Assumptions	'
	Weighted average option fair values and assumptions for the period specified are disclosed in the following table:
		Years Ended December 31,
		2013		2012		2011
	Weighted average fair value of grants	$12.97		$11.40		$12.30
	Dividend yield	1.57%		1.59%		1.46%
	Volatility	30.92%		32.00%		32.72%
	Risk-free interest rate	0.17% - 4.12%		0.17% - 3.96%		0.28% - 5.61%
	Expected life (in years)	5.86		5.98		6.14
Schedule of Weighted Average Performance Share Units Fair Values and Assumptions	'
	Weighted average performance share unit fair values and assumptions for the period specified are disclosed in the following table:
		Year Ended December 31,
		2013
	Weighted average fair value of grants	$59.58
	Dividend yield	—%
	Volatility	28.99%
	Risk-free interest rate	0.40%
	Expected life (in years)	2.87
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'
	Total compensation cost for performance share units is as follows:
		Year Ended December 31,
		2013
		(In thousands)
	Cost of goods sold	$	—
	Selling, general and administrative expenses	873
	Total expense before income taxes	873
	Income tax benefit	(280		)
	Total expense after income taxes	$	593
Schedule of Stock Option Activity	'
	A summary of the Company’s stock option activity as of December 31, 2013, and changes during the year ended December 31, 2013 is presented in the following table:
	Stock Options	Shares			Weighted				Weighted-Average		Aggregate
					Average				Remaining		Intrinsic
					Price				Contractual Term		Value
	Outstanding at January 1, 2013	3,223,742			$	33.16			6.37		$	43,106,153
	Granted	651,022			50.7
	Exercised	(1,245,817	)		28.41
	Forfeited/Expired	(112,329	)		43.23
	Outstanding at December 31, 2013	2,516,618			$	39.6			6.87		$	86,200,655
	Vested and expected to vest at December 31, 2013	2,400,548			$	39.23			6.78		$	83,095,331
	Exercisable at December 31, 2013	1,086,636			$	32.47			5.05		$	44,963,329
Schedule of Unvested Share Activity	'
	A summary of the Company’s unvested share activity as of December 31, 2013, and changes during the year ending December 31, 2013 is presented in the following table:
	Unvested Shares	Shares			Weighted-Average
					Grant Date Fair
					Value
	Nonvested at January 1, 2013	589,986			$	40.27
	Granted	232,418			56.2
	Vested	(154,795	)		38.5
	Forfeited	(48,930	)		53.58
	Nonvested at December 31, 2013	618,679			$	40.27
Schedule of Performance Share Units Activity	'
	A summary of the Company's performance share unit activity as of December 31, 2013, and changes during the year ending December 31, 2013 is presented in the following table:
	Performance Share Units	Shares			Weighted-Average
					Grant Date Fair
					Value
	Nonvested at January 1, 2013	—			$	—
	Granted	54,065			59.58
	Vested	—			—
	Forfeited	(860	)		59.58
	Nonvested at December 31, 2013	53,205			$	59.58
Stock Option	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Compensation Cost for Stock Options and Unvested Shares	'
	Total compensation cost for stock options is as follows:
		Years Ended December 31,
		2013				2012				2011
		(In thousands)
	Cost of goods sold	$	479			$	650			$	805
	Selling, general and administrative expenses	5,789				5,642				6,153
	Total expense before income taxes	6,268				6,292				6,958
	Income tax benefit	(2,016		)		(1,988		)		(2,208		)
	Total expense after income taxes	$	4,252			$	4,304			$	4,750
Unvested Shares	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Compensation Cost for Stock Options and Unvested Shares	'
	Total compensation cost for unvested shares is as follows:
		Years Ended December 31,
		2013				2012				2011(1)
		(In thousands)
	Cost of goods sold	$	1,380			$	991			$	684
	Selling, general and administrative expenses	8,471				5,819				4,434
	Total expense before income taxes	9,851				6,810				5,118
	Income tax benefit	(2,296		)		(1,682		)		(1,827		)
	Total expense after income taxes	$	7,555			$	5,128			$	3,291

Other_Comprehensive_Income_Los1

Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss)	'
	The components of other comprehensive income (loss) are as follows:
		For the Year Ended December 31, 2013												For the Year Ended December 31, 2012
		Pre-tax				Tax				Net of tax				Pre-tax				Tax			Net of tax
		(In thousands)
	Cumulative translation adjustment	$	13,572			$	—			$	13,572			$	14,445			$	—		$	14,445
	Pension and other postretirement adjustments
	Net gain (loss) arising during the year	26,274				(9,859		)		16,415				(16,607		)		3,107			(13,500		)
	Amortization/settlement recognition of net loss (gain)	8,599				(3,226		)		5,373				7,801				(1,460		)	6,341
	Pension and other postretirement adjustments, net	34,873				(13,085		)		21,788				(8,806		)		1,647			(7,159		)
	Reclassification adjustments for derivatives	7,430				(2,692		)		4,738				7,571				(2,791		)	4,780
	Total other comprehensive income (loss)	$	55,875			$	(15,777	)		$	40,098			$	13,210			$	(1,144	)	$	12,066
								For the Year Ended December 31, 2011
								Pre-tax				Tax				Net of tax
								(In thousands)
	Cumulative translation adjustment							$	(14,108	)		$	—			$	(14,108	)
	Pension and other postretirement adjustments
	Net gain (loss) arising during the year							(18,066		)		6,038				(12,028		)
	Amortization or settlement recognition of net loss (gain)							5,446				(1,816		)		3,630
	Pension and other postretirement adjustments, net							(12,620		)		4,222				(8,398		)
	Reclassification adjustments for derivatives							(32,754		)		12,500				(20,254		)
	Total other comprehensive income (loss)							$	(59,482	)		$	16,722			$	(42,760	)
Reclassification out of Accumulated Other Comprehensive Income	'
	Amounts reclassified from accumulated other comprehensive income (loss) to net income (loss) are summarized as follows:
			For the Years Ended December 31,
			2013				2012				2011				Income Statement Caption
	Pension and other postretirement plans:
	Amortization of service cost		$	8,599			$	7,801			$	5,446			Selling, general and administrative expense
	Total before tax		8,599				7,801				5,446
	Provision for income taxes		(3,226		)		(1,460		)		(1,816		)
	Total net of tax		$	5,373			$	6,341			$	3,630
	Derivatives:
	Reclassification adjustments		$	7,430			$	7,571			$	(32,754	)		Interest expense
	Total before tax		7,430				7,571				(32,754		)
	Provision for income taxes		(2,692		)		(2,791		)		12,500
	Total net of tax		$	4,738			$	4,780			$	(20,254	)

Retirement_Benefits_Tables

Retirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]	'
Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets	'
		Pension Benefits															Other Benefits
		2013								2012							2013			2012
		U.S.				Non-U.S.				U.S.			Non-U.S.
		(In thousands)
	CHANGE IN BENEFIT OBLIGATION
	Obligation at January 1	$	111,188			$	56,555			$	101,511		$	47,763			$	25,587		$	21,073
	Service cost	1,526				1,388				1,756			1,300				968			763
	Interest cost	3,766				2,146				4,247			2,206				906			922
	Plan amendments	—				—				59			410				—			159
	Benefits paid	(2,479		)		(1,957		)		(4,097		)	(3,536		)		(801		)	(704		)
	Actuarial loss (gain)	(11,885		)		581				13,202			6,700				(5,139		)	3,313
	Currency translation	—				1,758				—			1,712				(167		)	61
	Curtailments/settlements	(9,277		)		—				(5,490		)	—				—			—
	Acquisition	—				—				—			—				—			—
	Obligation at December 31	$	92,839			$	60,471			$	111,188		$	56,555			$	21,354		$	25,587
	CHANGE IN PLAN ASSETS
	Fair value of plan assets at January 1	$	74,578			$	19,660			$	59,619		$	16,914			$	—		$	—
	Actual return on plan assets	14,303				2,341				6,177			1,944				—			—
	Employer contributions(1)	4,832				1,840				17,287			3,514				801			704
	Benefits paid	(2,479		)		(1,957		)		(4,097		)	(3,536		)		(801		)	(704		)
	Currency translation	—				447				—			810				—			—
	Settlements	(9,277		)		3				(4,408		)	—				—			—
	Other	—				—				—			14				—			—
	Fair value of plan assets at December 31	$	81,957			$	22,334			$	74,578		$	19,660			$	—		$	—
	Funded status at December 31	$	(10,882	)		$	(38,138	)		$	(36,610	)	$	(36,894	)		$	(21,354	)	$	(25,587	)
	COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS
	Current liabilities	$	(656	)		$	(995	)		$	(588	)	$	(743	)		$	(946	)	$	(907	)
	Other noncurrent liabilities	(10,226		)		(37,143		)		(36,022		)	(36,151		)		(20,408		)	(24,680		)
	Net liability at December 31	$	(10,882	)		$	(38,138	)		$	(36,610	)	$	(36,894	)		$	(21,354	)	$	(25,587	)
	-1	Includes $10.0 million discretionary contribution to U.S. plan in 2012.
Weighted Average Assumptions Used in Measurement of Benefit Obligation	'
	The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2013 and 2012 were as follows:
		U.S. Plans						Non-U.S.
								Plans
		2013			2012			2013			2012
	Discount rate	4.61	%		3.56	%		4.03	%		3.91	%
	Rate of compensation increase	4	%		3.94	%		3.14	%		2.99	%
Pretax Amounts Recognized in Accumulated Other Comprehensive Income (Loss)	'
	The pretax amounts recognized in Accumulated other comprehensive income (loss) as of December 31, 2013 and 2012 were as follows:
		Pension Benefits															Other Benefits
		2013								2012							2013			2012
		U.S.				Non-U.S.				U.S.			Non-U.S
		(In thousands)
	Prior service cost (credit)	$	170			$	312			$	275		$	330			$	(1,951	)	$	(2,325	)
	Net loss	22,854				14,262				51,240			15,496				(225		)	5,279
	Total	$	23,024			$	14,574			$	51,515		$	15,826			$	(2,176	)	$	2,954
Amounts in Accumulated Other Comprehensive Income (Loss) Expected to Be Recognized as Components of Net Periodic Benefit Cost During 2012	'
	The amounts in Accumulated other comprehensive income (loss) as of December 31, 2013, that are expected to be recognized as components of net periodic benefit cost during 2014 are as follows:
		U.S. Pension				Non-U.S.				Other			Total
		Benefit Plans				Pension Benefit				Benefit Plans
						Plans
		(In thousands)
	Prior service cost (credit)	$	84			$	26			$	(371	)	$	(261	)
	Net loss	2,306				851				(105		)	3,052
	Total	$	2,390			$	877			$	(476	)	$	2,791
Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost of Plans	'
		U.S. Plans									Non-U.S. Plans
		2013			2012			2011			2013		2012			2011
	Discount rate	3.56	%		4.45	%		5.2	%		3.91	%	4.68	%		5.35	%
	Expected return on plan assets	7.5	%		8	%		8.25	%		5.53	%	5.9	%		6.17	%
	Rate of compensation increase	3.94	%		3.9	%		3.9	%		2.99	%	2.96	%		3.37	%
Pension Plan Weighted Average Asset Allocations	'
	The Company’s pension plan weighted average asset allocations at December 31, 2013 and 2012, by asset category, were as follows:
		2013			2012
	Equity securities	66	%		68	%
	Fixed income securities	34	%		32	%
	Total	100	%		100	%
Summary of Basis Used to Measure Defined Benefit Plans' Assets at Fair Value	'
	The following tables summarize the basis used to measure the defined benefit plans’ assets at fair value at December 31, 2013 and 2012:
		Basis of Fair Value Measurement
		Outstanding				Level 1				Level 2			Level 3
		Balances
	As of December 31, 2013	(In thousands)
	Equity
	U.S. Large Cap	$	31,831			$	31,831			$	—		$	—
	U.S. Small / Mid Cap	8,783				8,783				—			—
	International	25,591				25,591				—			—
	Fixed Income
	U.S. Intermediate	18,715				18,715				—			—
	U.S. Short Duration	8,954				8,954				—			—
	U.S. High Yield	1,581				1,581				—			—
	International	5,812				5,812				—			—
	Other
	Insurance Contracts	331				—				331			—
	Cash and Equivalents	2,693				2,693				—			—
		$	104,291			$	103,960			$	331		$	—
		Basis of Fair Value Measurement
		Outstanding				Level 1				Level 2			Level 3
		Balances
	As of December 31, 2012	(In thousands)
	Equity
	U.S. Large Cap	$	32,496			$	32,496			$	—		$	—
	U.S. Small / Mid Cap	7,770				7,770				—			—
	International	20,869				13,082				7,787			—
	Fixed Income
	U.S. Intermediate	25,069				25,069				—			—
	U.S. Short Duration	—				—				—			—
	U.S. High Yield	—				—				—			—
	International	5,489				5,489				—			—
	Other
	Insurance Contracts	326				326				—			—
	Cash and Equivalents	2,219				2,219				—			—
		$	94,238			$	86,451			$	7,787		$	—
Net Periodic Benefit Cost	'
Defined Benefit Plan Disclosure [Line Items]	'
Pretax Amounts Recognized in Accumulated Other Comprehensive Income (Loss)	'
	The following table provides the pretax change recognized in Accumulated other comprehensive income (loss) in 2013:
		Pension Benefits
		U.S.				Non-U.S.				Other
										Benefits
		(In thousands)
	Net loss in current year	$	20,869			$	708			$	5,140
	Prior service cost	—				—				—
	Amortization of prior service cost (credit)	104				25				(373		)
	Amortization of net loss	7,518				929				396
	Exchange rate effect on amounts in OCI	—				(410		)		(33		)
	Total	$	28,491			$	1,252			$	5,130
Pension Plans	'
Defined Benefit Plan Disclosure [Line Items]	'
Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans	'
	The following tables provide the components of, and the weighted average assumptions used to determine, the net periodic benefit cost for the plans in 2013, 2012 and 2011:
		Pension Benefits
		2013								2012							2011
		U.S.				Non-U.S.				U.S.			Non-U.S.				U.S.			Non-U.S.
		(In thousands)
	Service cost	$	1,526			$	1,388			$	1,756		$	1,300			$	1,759		$	1,078
	Interest cost	3,766				2,146				4,247			2,206				4,506			2,320
	Expected return on plan assets	(5,318		)		(1,055		)		(4,687		)	(1,035		)		(4,755		)	(1,117		)
	Net amortization	7,621				955				5,376			589				4,855			442
	Net periodic benefit cost	$	7,595			$	3,434			$	6,692		$	3,060			$	6,365		$	2,723
Other Postretirement Benefit Plans	'
Defined Benefit Plan Disclosure [Line Items]	'
Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans	'
		Other Benefits
		2013				2012				2011
		(In thousands)
	Service cost	$	968			$	763			$	691
	Interest cost	906				922				1,035
	Net amortization	24				11				(156		)
	Net periodic benefit cost	$	1,898			$	1,696			$	1,570

Quarterly_Results_of_Operation1

Quarterly Results of Operations (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Summarized Quarterly Results of Operations	'
	The following table summarizes the unaudited quarterly results of operations for the years ended December 31, 2013 and 2012.
		2013 Quarters								2012 Quarters
		First		Second		Third		Fourth		First		Second		Third		Fourth(1)
		(In thousands, except per share amounts)
	Net sales	$	494,448	$	518,445	$	490,617	$	520,620	$	489,417	$	494,144	$	479,859	$	490,838
	Gross profit	211,997		222,849		211,509		227,009		202,889		203,113		194,840		202,858
	Operating income (loss)	94,712		99,559		97,369		103,873		84,569		88,650		80,588		(125,589		)
	Net income (loss)	61,300		62,561		63,799		67,555		52,171		54,351		50,127		(119,019		)
	Basic EPS	$	0.74	$	0.76	$	0.78	$	0.83	$	0.63	$	0.65	$	0.6	$	(1.45	)
	Diluted EPS	$	0.74	$	0.76	$	0.78	$	0.82	$	0.62	$	0.65	$	0.6	$	(1.45	)
	Basic weighted average shares outstanding	82,197		81,829		81,259		80,782		82,804		83,180		82,482		82,296
	Diluted weighted average shares outstanding	83,152		82,734		82,218		81,854		83,902		84,090		83,370		82,296
	-1	Fourth quarter 2012 includes a $198.5 million asset impairment charge.

Significant_Accounting_Policie3

Significant Accounting Policies - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	segment
Accounting Policies [Abstract]	'	'	'
Number of reportable segments	3	'	'
Advertising costs	$14.60	$15.30	$13.40
Highly liquid debt instruments, maturity period	'90B days or less	'	'
(Increase) decrease in income attributable to common shareholders	1.2	0.1	1.2
Option to purchase common stock shares not included in the computation of diluted EPS	0	1.2	0.7
Research and development expense	$33	$36.40	$36
Percentage of concentration risk	2.00%	'	'

Schedule_of_Basic_Weighted_Ave

Schedule of Basic Weighted Average Shares Reconciles to Diluted Weighted Average Shares Outstanding (Detail)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accounting Policies [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Basic weighted average common shares outstanding	80,782	81,259	81,829	82,197	82,296	82,482	83,180	82,804	81,517	82,689	82,145
Dilutive effect of stock options, unvested shares, performance share units and DCUs	'	'	'	'	'	'	'	'	972	952	1,398
Diluted weighted average common shares outstanding	81,854	82,218	82,734	83,152	82,296	83,370	84,090	83,902	82,489	83,641	83,543

Property_And_Equipment_at_Cost

Property And Equipment at Cost Depreciation and Amortization Estimated Useful Lives (Detail)	12 Months Ended
	Dec. 31, 2013
Land improvements | Minimum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'8 years
Land improvements | Maximum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'12 years
Buildings and improvements | Minimum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'8 years
Buildings and improvements | Maximum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'30 years
Machinery, equipment and other | Minimum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'3 years
Machinery, equipment and other | Maximum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'12 years
Office and transportation equipment | Minimum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'3 years
Office and transportation equipment | Maximum	'
Property, Plant and Equipment [Line Items]	'
Estimated useful life	'10 years

Intangible_Asset_Depreciation_

Intangible Asset Depreciation and Amortization Estimated Useful Lives (Detail)	12 Months Ended
	Dec. 31, 2013
Patents	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'11 years
Patents | Minimum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'5 years
Patents | Maximum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'17 years
Trade Names	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'16 years
Trade Names | Minimum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'10 years
Trade Names | Maximum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'20 years
Customer Relationships	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'10 years
Customer Relationships | Minimum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'4 years 6 months
Customer Relationships | Maximum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'20 years
Non-Compete Agreements	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'3 years
Non-Compete Agreements | Minimum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'2 years 6 months
Non-Compete Agreements | Maximum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'3 years
Unpatented technology and other	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'11 years
Unpatented technology and other | Minimum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'4 years 6 months
Unpatented technology and other | Maximum	'
Finite-Lived Intangible Assets [Line Items]	'
Estimated useful life	'20 years

Restructuring_Additional_Infor

Restructuring - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]	'	'	'
Pre-tax restructuring expenses related to restructuring initiative	$0	$32,473	$12,314
2011 restructuring initiative	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Pre-tax restructuring expenses related to restructuring initiative	0	32,473	12,314
Number of employees	491	292	'
Restructuring liabilities	$0	$10,887	$5,875

Schedule_of_PreTax_Restructuri

Schedule of Pre-Tax Restructuring Expenses by Segment (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]	'	'	'
Total	$0	$32,473	$12,314
Fluid & Metering Technologies	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Severance Costs	'	6,226	2,800
Exit Costs	'	36	61
Total	'	6,262	2,861
Health & Science Technologies	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Severance Costs	'	11,223	2,007
Exit Costs	'	3,521	123
Total	'	14,744	2,130
Fire & Safety/Diversified Products	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Severance Costs	'	3,226	4,430
Exit Costs	'	5,114	797
Total	'	8,340	5,227
Corporate Office/Other	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Severance Costs	'	2,844	2,096
Exit Costs	'	283	0
Total	'	3,127	2,096
Total Restructuring Costs	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Severance Costs	'	23,519	11,333
Exit Costs	'	8,954	981
Total	'	$32,473	$12,314

Schedule_of_Restructuring_Accr

Schedule of Restructuring Accruals Expenses (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restructuring Reserve [Roll Forward]	'	'	'
Restructuring expenses	$0	$32,473	$12,314
2011 restructuring initiative	'	'	'
Restructuring Reserve [Roll Forward]	'	'	'
Beginning balance	10,887	5,875	'
Restructuring expenses	0	32,473	12,314
Payments, utilization and other	-10,887	-27,461	'
Ending balance	$0	$10,887	$5,875

Balance_Sheet_Components_Detai

Balance Sheet Components (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Additional Financial Information Disclosure [Abstract]	'	'
Customers	$255,992	$257,114
Other	3,075	4,577
Total	259,067	261,691
Less allowance for doubtful accounts	5,841	5,596
Total receivables - net	253,226	256,095
Raw materials and components parts	133,470	139,229
Work in process	41,895	33,025
Finished goods	55,602	62,696
Total	230,967	234,950
Land and improvements	32,723	31,787
Buildings and improvements	150,316	141,952
Machinery, equipment and other	300,858	288,542
Office and transportation equipment	95,923	95,920
Construction in progress	9,201	12,040
Total	589,021	570,241
Less accumulated depreciation and amortization	375,533	351,080
Total property, plant and equipment - net	213,488	219,161
Payroll and related items	63,297	55,618
Management incentive compensation	20,949	15,974
Income taxes payable	11,746	10,284
Deferred income taxes	0	0
Insurance	7,741	8,974
Warranty	4,888	4,875
Deferred revenue	9,455	9,682
Restructuring	0	10,887
Liability for uncertain tax positions	1,201	2,679
Accrued interest	1,354	1,713
Contingent consideration for acquisition	0	3,528
Other	30,120	25,962
Total accrued expenses	150,751	150,176
Pension and retiree medical obligations	67,777	96,853
Liability for uncertain tax positions	4,624	4,989
Deferred revenue	5,578	6,534
Contingent consideration for acquisition	0	5,515
Other	15,087	14,484
Total other noncurrent liabilities	$93,066	$128,375

Balance_Sheet_Components_Valua

Balance Sheet Components Valuation And Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Movement in Valuation Allowances and Reserves [Roll Forward]	'		'		'
Beginning balance January 1	$5,596	[1]	$5,860	[1]	$5,322	[1]
Charged to costs and expenses, net of recoveries	2,288	[1]	653	[1]	1,044	[1]
Utilization	-1,921	[1]	-1,151	[1]	-917	[1]
Currency translation and other	-122	[1]	234	[1]	411	[1]
Ending balance December 31	$5,841	[1]	$5,596	[1]	$5,860	[1]
[1]	(1)Includes provision for doubtful accounts, sales returns and sales discounts granted to customers.

Schedule_of_Changes_in_Carryin

Schedule of Changes in Carrying Amount of Goodwill (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Line Items]	'	'
Goodwill, gross	'	$1,461,456
Accumulated impairment losses	'	-30,090
Beginning Balance	1,321,727	1,431,366
Acquisition adjustments	'	1,424
Acquisitions (Note 12)	17,994	50,387
Foreign currency translation	9,735	9,091
Goodwill impairment	'	-170,541
Ending Balance	1,349,456	1,321,727
Fluid & Metering Technologies	'	'
Goodwill and Intangible Assets Disclosure [Line Items]	'	'
Goodwill, gross	'	541,640
Accumulated impairment losses	'	0
Beginning Balance	524,325	541,640
Acquisition adjustments	'	0
Acquisitions (Note 12)	0	0
Foreign currency translation	3,719	3,406
Goodwill impairment	-20,700	-20,721
Ending Balance	528,044	524,325
Health & Science Technologies	'	'
Goodwill and Intangible Assets Disclosure [Line Items]	'	'
Goodwill, gross	'	648,906
Accumulated impairment losses	'	0
Beginning Balance	553,204	648,906
Acquisition adjustments	'	1,424
Acquisitions (Note 12)	17,994	50,387
Foreign currency translation	477	2,307
Goodwill impairment	-149,800	-149,820
Ending Balance	571,675	553,204
Fire & Safety/Diversified Products	'	'
Goodwill and Intangible Assets Disclosure [Line Items]	'	'
Goodwill, gross	'	270,910
Accumulated impairment losses	'	-30,090
Beginning Balance	244,198	240,820
Acquisition adjustments	'	0
Acquisitions (Note 12)	0	0
Foreign currency translation	5,539	3,378
Goodwill impairment	'	0
Ending Balance	$249,737	$244,198

Schedule_of_Gross_Carrying_Val

Schedule of Gross Carrying Value and Accumulated Amortization for Each Major Class of Intangible Asset (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	$444,184	$429,063
Intangible assets - Gross Carrying Amount	506,284	491,163
Amortized intangible assets - Accumulated Amortization	-195,057	-149,791
Amortized intangible assets - Net	249,127	279,272
Intangible assets - Net	311,227	341,372
Patents	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	10,673	10,650
Amortized intangible assets - Accumulated Amortization	-5,179	-4,273
Amortized intangible assets - Net	5,494	6,377
Amortized intangible assets - Weighted Average Life	'11 years	'
Trade Names	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	104,582	103,113
Amortized intangible assets - Accumulated Amortization	-28,310	-21,603
Amortized intangible assets - Net	76,272	81,510
Amortized intangible assets - Weighted Average Life	'16 years	'
Customer Relationships	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	242,674	230,196
Amortized intangible assets - Accumulated Amortization	-121,092	-93,273
Amortized intangible assets - Net	121,582	136,923
Amortized intangible assets - Weighted Average Life	'10 years	'
Non-Compete Agreements	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	3,769	3,505
Amortized intangible assets - Accumulated Amortization	-3,272	-2,827
Amortized intangible assets - Net	497	678
Amortized intangible assets - Weighted Average Life	'3 years	'
Unpatented technology and other	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	75,528	74,758
Amortized intangible assets - Accumulated Amortization	-32,905	-24,211
Amortized intangible assets - Net	42,623	50,547
Amortized intangible assets - Weighted Average Life	'11 years	'
Other Amortizable Intangible Assets	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Amortized intangible assets - Gross Carrying Amount	6,958	6,841
Amortized intangible assets - Accumulated Amortization	-4,299	-3,604
Amortized intangible assets - Net	2,659	3,237
Amortized intangible assets - Weighted Average Life	'10 years	'
Banjo Trade Name	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Indefinite lived intangible assets - Gross Carrying Amount	62,100	62,100
Indefinite lived intangible assets - Net	$62,100	$62,100

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Goodwill and Intangible Assets Disclosure [Line Items]	'	'	'
IPO reporting units, fair value, percent grader than carrying value	10.00%	'	'
Goodwill impairment	'	($170,541,000)	'
Trade name, impairment charge	2,700,000	'	'
Long lived assets impairment charge	7,000,000	'	'
Amortization of intangible assets	44,327,000	41,485,000	35,504,000
Expected amortization expense, 2014	43,300,000	'	'
Expected amortization expense, 2015	41,100,000	'	'
Expected amortization expense, 2016	39,100,000	'	'
Expected amortization expense, 2017	30,000,000	'	'
Expected amortization expense, 2018	18,300,000	'	'
Trade Name	'	'	'
Goodwill and Intangible Assets Disclosure [Line Items]	'	'	'
Trade name, impairment charge	'	21,000,000	'
Trade name, fair value	'	26,000,000	'
Estimated useful life	'	'15 years	'
Health & Science Technologies	'	'	'
Goodwill and Intangible Assets Disclosure [Line Items]	'	'	'
Goodwill impairment	-149,800,000	-149,820,000	'
Fluid & Metering Technologies	'	'	'
Goodwill and Intangible Assets Disclosure [Line Items]	'	'	'
Goodwill impairment	($20,700,000)	($20,721,000)	'

Schedule_of_Borrowings_Detail

Schedule of Borrowings (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'	'
Long-term borrowings	$773,876	$786,576
Less current portion	1,871	7,335
Total long-term borrowings	772,005	779,241
Other Borrowings	'	'
Debt Instrument [Line Items]	'	'
Other borrowings	4,271	10,648
Revolving Credit Facility	'	'
Debt Instrument [Line Items]	'	'
Revolving Facility	10,000	21,000
4.2% Senior Notes	'	'
Debt Instrument [Line Items]	'	'
Long-term borrowings	349,272	349,197
4.5 % Senior Notes	'	'
Debt Instrument [Line Items]	'	'
Long-term borrowings	298,828	298,689
2.58% Senior Euro Notes	'	'
Debt Instrument [Line Items]	'	'
Long-term borrowings	$111,505	$107,042

Schedule_of_Borrowings_Parenth

Schedule of Borrowings (Parenthetical) (Detail)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
4.2% Senior Notes	'	'	'
Debt Instrument [Line Items]	'	'	'
Stated interest rate	4.20%	'	4.20%
Senior Notes, maturity date	'2021-12	'2021-12	'
4.5 % Senior Notes	'	'	'
Debt Instrument [Line Items]	'	'	'
Stated interest rate	4.50%	'	'
Senior Notes, maturity date	'2020-12	'2020-12	'
2.58% Senior Euro Notes	'	'	'
Debt Instrument [Line Items]	'	'	'
Stated interest rate	2.58%	'	'
Senior Notes, maturity date	'2015-06	'2015-06	'

Borrowings_Additional_Informat

Borrowings - Additional Information (Detail)

12 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Jun. 30, 2010

Jun. 30, 2010

Jun. 09, 2010

Dec. 31, 2013

Dec. 31, 2010

Dec. 06, 2010

Apr. 15, 2010

Dec. 31, 2011

Dec. 31, 2013

Dec. 09, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

USD ($)

2.58% Senior Euro Notes

2.58% Senior Euro Notes

2.58% Senior Euro Notes

2.58% Senior Euro Notes

4.5 % Senior Notes

4.5 % Senior Notes

4.5 % Senior Notes

4.2% Senior Notes

4.2% Senior Notes

4.2% Senior Notes

Other Borrowings

Other Borrowings

Other Borrowings

Other Borrowings

Letters Of Credit

Swing line Loans

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

USD ($)

EUR (€)

USD ($)

Minimum

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum

Maximum

USD ($)

USD ($)

USD ($)

USD ($)

Minimum

Maximum

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Replaced credit facility due to expire

$600,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving facility principal amount

700,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

75,000,000

25,000,000

'

'

'

'

Revolving facility expiration date

27-Jun-16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate commitments of designated borrowers under the Credit Facility

950,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Applicable margin over LIBOR

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.05%

'

0.88%

1.70%

Basis spread on variable rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.20%

'

'

'

Leverage ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.25

Outstanding letters of credit

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,700,000

'

'

'

Current borrowings under revolving facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

21,000,000

'

'

Revolving Facility, amount available to borrow

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

681,300,000

'

'

'

Principal amount of private placement

'

96,800,000

81,000,000

'

'

'

'

'

350,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Stated interest rate

'

'

'

2.58%

'

'

4.50%

4.50%

'

'

4.20%

'

'

0.30%

1.50%

'

'

'

'

'

'

Debt instrument maturity period

'

9-Jun-15

9-Jun-15

'

'

15-Dec-20

'

'

15-Dec-21

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument maximum amount outstanding

'

'

'

750,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayment, minimum percentage outstanding

'

5.00%

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument face amount

'

'

'

'

'

'

300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net proceeds from debt offering

'

'

'

'

'

'

295,700,000

'

'

'

346,200,000

'

'

'

'

'

'

'

'

'

'

Debt offering initial discount

'

'

'

'

'

'

1,600,000

'

'

'

900,000

'

'

'

'

'

'

'

'

'

'

Debt offering underwriting commission

'

'

'

'

'

1,900,000

'

'

2,300,000

'

'

'

'

'

'

'

'

'

'

'

'

Estimated offering expenses

'

'

'

'

'

800,000

'

'

600,000

'

'

'

'

'

'

'

'

'

'

'

'

Contingent percentage of principal amount plus accrued and unpaid interest

'

'

'

'

'

101.00%

'

'

'

101.00%

'

'

'

'

'

'

'

'

'

'

'

Outstanding repayment of indebtedness

'

'

'

'

'

250,000,000

'

'

306,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Other borrowings

'

'

'

'

'

'

'

'

'

'

'

$4,271,000

$10,648,000

'

'

'

'

'

'

'

'

Interest coverage ratio

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Schedule_of_Maturities_of_Borr

Schedule of Maturities of Borrowings (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]	'	'
2014	$1,871	'
2015	112,085	'
2016	10,530	'
2017	1,190	'
2018	100	'
Thereafter	648,100	'
Long-term borrowings	$773,876	$786,576

Derivative_Instruments_Additio

Derivative Instruments - Additional Information (Detail) (USD $)

1 Months Ended

12 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

Dec. 31, 2011

Sep. 30, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 29, 2011

Dec. 31, 2010

Apr. 30, 2010

Dec. 31, 2011

Apr. 15, 2010

Oct. 31, 2011

Jul. 31, 2011

Jul. 12, 2011

Dec. 31, 2011

Dec. 31, 2012

Dec. 06, 2010

Apr. 15, 2010

Interest Rate Exchange Agreement Expiring 2010

Interest Rate Exchange Agreement Expiring 2010

Interest Rate Exchange Agreement Expiring 2010

Interest Rate Exchange Agreement Expiring 2010

Interest Rate Exchange Agreement Expiring 2011

Interest Rate Exchange Agreement Expiring 2011

Interest Rate Exchange Agreement Expiring 2011

Interest Rate Exchange Agreements Expiring 2011 And 2012

Interest Rate Exchange Agreements Expiring 2011 And 2012

4.5 % Senior Notes

4.5 % Senior Notes

Derivative [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate contract with notional amount

'

'

'

'

'

$350,000,000

'

'

'

$300,000,000

'

'

$350,000,000

'

'

'

'

Interest rate exchange agreement expiration date

'

28-Feb-12

'

'

'

'

'

31-Dec-10

'

'

'

30-Sep-11

'

'

'

'

'

Interest rate on senior notes

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.50%

4.50%

Interest rate contract settlement amount

'

'

'

'

'

'

31,000,000

'

'

'

34,700,000

'

'

'

'

'

'

Future amortization interest expense over 10 year periods

'

'

1,703,000

1,685,000

1,263,000

'

31,000,000

'

'

'

'

'

'

37,900,000

'

'

'

Term of amortized interest expense, years

'

'

'

'

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

Interest rate

'

'

'

'

'

'

'

'

5.80%

'

'

'

'

'

5.30%

'

'

Additional interest rate contract settlement

4,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Settlement amount interest rate contract

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38,700,000

'

'

Interest rate settlement recognized as other expense

'

'

'

'

'

'

'

'

'

'

'

'

'

800,000

'

'

'

Amount to be recognized from hedged transactions within 12 months, approximate

'

'

$7,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Summary_of_Gain_or_Loss_Recogn

Summary of Gain or Loss Recognized and Amounts and Location of Income or Expense and Gain or Loss Reclassified into Income for Interest Rate Contracts and Foreign Currency Contracts (Detail) (Interest rate agreements, Interest Expense, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Interest rate agreements | Interest Expense	'	'	'
Derivative [Line Items]	'	'	'
Gain(Loss) recognized in Other comprehensive Income	$0	$0	$0
Income (Expense) and Gain (Loss) Reclassified into Income	($7,430)	($7,637)	($3,570)

Schedule_of_Company_Financial_

Schedule of Company Financial Assets and Liabilities at Fair Value on Recurring Basis (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Money market investments	$27,871	$11,165
Available for sale securities	3,255	2,862
Contingent consideration	'	-9,043
Level 1	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Money market investments	27,871	11,165
Available for sale securities	3,255	2,862
Contingent consideration	'	0
Level 2	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Money market investments	0	0
Available for sale securities	0	0
Contingent consideration	'	0
Level 3	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Money market investments	0	0
Available for sale securities	0	0
Contingent consideration	'	($9,043)

Fair_Value_Measurements_Additi

Fair Value Measurements - Additional Information (Detail) (USD $)	12 Months Ended						1 Months Ended		3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Jan. 31, 2011	Nov. 30, 2013	Apr. 30, 2013	Dec. 31, 2012	Dec. 31, 2013	Jul. 20, 2012
			2.58% Senior Euro Notes	Senior Notes	4.2% Senior Notes	At Films	Matcon	Matcon	Matcon	Matcon	Matcon
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Contingent consideration value as of opening balance sheet date	'	$9,043,000	'	'	'	$2,700,000	'	'	$9,000,000	$4,900,000	$8,400,000
Business acquisition, contingent consideration recognized to SG&A	1,400,000	2,700,000	'	'	'	'	4,100,000	'	600,000	'	'
Contingent consideration for acquisition recorded in Accrued expenses	0	3,528,000	'	'	'	'	'	'	3,500,000	'	'
Contingent consideration for acquisition recorded in Noncurrent liabilities	0	5,515,000	'	'	'	'	'	'	5,500,000	'	'
Change in amount of contingent consideration, liability	'	'	'	'	'	'	1,100,000	3,800,000	'	'	'
Stated interest rate	'	'	2.58%	4.50%	4.20%	'	'	'	'	'	'
Fair value of our revolving facility and senior debt	772,900,000	'	'	'	'	'	'	'	'	'	'
Carrying value of our revolving facility and senior debt	$769,600,000	'	'	'	'	'	'	'	'	'	'

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Commitments and Contingencies Disclosure [Abstract]	'	'	'
Rental expense	$18.90	$18.40	$19

Future_Minimum_Lease_Payments_

Future Minimum Lease Payments For Operating And Capital Leases (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]	'
Future minimum lease payments for operating lease for year 2014	$15,426
Future minimum lease payments for operating lease for year 2015	11,811
Future minimum lease payments for operating lease for year 2016	7,742
Future minimum lease payments for operating lease for year 2017	5,177
Future minimum lease payments for operating lease for year 2018	3,964
Future minimum lease payments for operating lease for year 2019 and thereafter	5,945
Future minimum lease payments for operating lease total	50,065
Future minimum lease payments for capital lease for year 2014	564
Future minimum lease payments for capital lease for year 2015	604
Future minimum lease payments for capital lease for year 2016	548
Future minimum lease payments for capital lease for year 2017	1,192
Future minimum lease payments for capital lease for year 2018	100
Future minimum lease payments for capital lease for year 2019 and thereafter	0
Future minimum lease payments for capital lease total	$3,008

Roll_Forward_Of_The_Warranty_R

Roll Forward Of The Warranty Reserve (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]	'	'	'
Beginning balance January 1st	$4,875	$4,417	$3,831
Provision for warranties	3,845	5,398	4,648
Claim settlements	-3,865	-5,214	-4,443
Other adjustments, including acquisitions and currency translation	33	274	381
Ending balance December 31st	$4,888	$4,875	$4,417

Common_and_Preferred_Stock_Add

Common and Preferred Stock - Additional Information (Detail) (USD $)	0 Months Ended	12 Months Ended
	Nov. 08, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity [Abstract]	'	'	'	'
Increase in share repurchase authorized amount	$300,000,000	'	'	'
Purchase of common stock (in shares)	'	2,916,280	2,182,946	'
Purchase of common stock	'	167,503,000	89,563,000	0
Remaining authorized repurchase amount	'	$368,000,000	'	'
Common stock, shares authorized	'	150,000,000	150,000,000	'
Common stock, par value	'	$0.01	$0.01	'
Preferred stock, shares authorized	'	5,000,000	5,000,000	'
Preferred stock, par value	'	$0.01	$0.01	'
Preferred stock, shares issued	'	0	0	'

Schedule_Of_Income_Before_Inco

Schedule Of Income Before Income Tax (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Domestic	$233,530	$65,738	$192,857
Foreign	119,599	20,466	81,024
Income before income taxes	$353,129	$86,204	$273,881

Provision_Benefit_for_Income_T

Provision Benefit for Income Taxes (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Current, U.S.	$59,707	$59,811	$48,823
Current, State and local	8,123	5,764	3,434
Current, Foreign	33,240	20,228	31,343
Total current	101,070	85,803	83,600
Deferred, U.S.	1,500	-31,246	4,792
Deferred, State and local	-55	-2,377	-1,103
Deferred, Foreign	-4,601	-3,606	-7,265
Total deferred	-3,156	-37,229	-3,576
Total provision for income taxes	$97,914	$48,574	$80,024

Deferred_Tax_Assets_Liabilitie

Deferred Tax Assets Liabilities (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Income Tax Disclosure [Abstract]	'	'
Employee and retiree benefit plans	$27,361	$38,401
Depreciation and amortization	-175,894	-170,630
Inventories	9,627	10,851
Allowances and accruals	9,632	7,629
Interest rate exchange agreement	18,165	20,856
Other	4,636	7,059
Net deferred tax liabilities	($106,473)	($85,834)

Deferred_Tax_Assets_and_Liabil

Deferred Tax Assets and Liabilities Recognized in Company's Consolidated Balance Sheets (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Income Tax Disclosure [Abstract]	'	'
Deferred tax asset - other current assets	$34,151	$32,293
Deferred tax asset - other noncurrent assets	4,284	3,222
Total deferred tax assets	38,435	35,515
Deferred tax liability - accrued expenses	0	0
Noncurrent deferred tax liability - deferred income taxes	-144,908	-121,349
Total deferred tax liabilities	-144,908	-121,349
Net deferred tax liabilities	($106,473)	($85,834)

Computed_Amount_and_Difference

Computed Amount and Differences in Provision for Income Taxes (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Pretax income	$353,129	$86,204	$273,881
Computed amount at statutory rate of 35%	123,595	30,171	95,858
State and local income tax (net of federal tax benefit)	4,382	2,406	1,515
Taxes on non-U.S. earnings-net of foreign tax credits	-9,683	1,189	-4,522
Effect of flow-through entities	-7,267	-7,846	-6,922
Asset impairments	0	28,524	0
U.S. business tax credits	-1,516	0	-917
Domestic activities production deduction	-6,217	-5,267	-4,589
Other	-5,380	-603	-399
Total provision for income taxes	$97,914	$48,574	$80,024

Computed_Amount_and_Difference1

Computed Amount and Differences in Provision for Income Taxes (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Statutory tax rate	35.00%	35.00%	35.00%

Reconciliation_of_Beginning_an

Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'	'	'
Beginning Balance	$6,506	$5,548	$6,440
Gross increases for tax positions of prior years	1,357	3,017	1,828
Gross decreases for tax positions of prior years	-99	-98	-1,595
Settlements	-1,219	0	-338
Lapse of statute of limitations	-1,421	-1,961	-787
Ending Balance	$5,124	$6,506	$5,548

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Line Items]	'	'	'
Undistributed earnings of non-U.S. subsidiaries	$597,000,000	$468,000,000	'
Foreign earnings repatriated	11,700,000	'	'
Incremental income tax expense	900,000	'	'
Accrued interest related to uncertain tax positions	500,000	700,000	500,000
Accrued penalties related to uncertain tax positions	200,000	500,000	200,000
Unrecognized tax benefits that would affect our effective tax rate	4,500,000	5,800,000	5,000,000
Unrecognized tax benefits possible change, estimated range, lower bound	0	'	'
Unrecognized tax benefits possible change, estimated range, upper bound	1,200,000	'	'
Loss carry forwards for U.S. federal	9,400,000	13,900,000	'
Loss carry forwards for non-U.S.	7,000,000	7,800,000	'
Loss carry forwards, subject to expiration amount	2,700,000	'	'
Loss carry forwards, not subject to expiration amount	4,300,000	'	'
Foreign capital loss carry forward	1,000,000	1,000,000	'
Deferred tax assets, capital loss carry forwards	200,000	200,000	'
Operating loss and credit carry forwards	22,400,000	38,800,000	'
Operating loss carry forwards, valuation allowance	$700,000	$1,500,000	'
Federal | Minimum	'	'	'
Income Tax Disclosure [Line Items]	'	'	'
Operating loss carry forwards, expiration dates	31-Dec-18	'	'
Federal | Maximum	'	'	'
Income Tax Disclosure [Line Items]	'	'	'
Operating loss carry forwards, expiration dates	31-Dec-31	'	'
State and Local Jurisdiction | Minimum	'	'	'
Income Tax Disclosure [Line Items]	'	'	'
Operating loss carry forwards, expiration dates	31-Dec-20	'	'
State and Local Jurisdiction | Maximum	'	'	'
Income Tax Disclosure [Line Items]	'	'	'
Operating loss carry forwards, expiration dates	31-Dec-33	'	'

Business_Segments_and_Geograph2

Business Segments and Geographic Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013
	segment
Segment Reporting [Abstract]	'
Number of reportable business segments	3

Schedule_of_Information_on_Com

Schedule of Information on Company's Business Segments (Detail) (USD $)

3 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

$2,024,130

$1,954,258

$1,838,451

Net sales

520,620

490,617

518,445

494,448

490,838

479,859

494,144

489,417

2,024,130

1,954,258

1,838,451

Operating income (loss)

103,873

97,369

99,559

94,712

-125,589

80,588

88,650

84,569

395,513

[1]

128,218

[1]

304,656

[1]

Interest expense

'

'

'

'

'

'

'

'

42,206

42,250

29,332

Other income (expense)-net

'

'

'

'

'

'

'

'

-178

236

-1,443

Income before taxes

'

'

'

'

'

'

'

'

353,129

86,204

273,881

Total assets

2,887,577

'

'

'

2,785,390

'

'

'

2,887,577

2,785,390

2,836,107

Depreciation and amortization

'

'

'

'

'

'

'

'

79,334

[2]

78,312

[2]

72,386

[2]

Total capital expenditures

'

'

'

'

'

'

'

'

31,536

35,520

34,548

Intersegment Eliminations

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Net sales

'

'

'

'

'

'

'

'

-7,383

-11,318

-3,161

Corporate Office

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Operating income (loss)

'

'

'

'

'

'

'

'

-55,180

[1]

-51,717

[1]

-52,100

[1]

Total assets

264,540

'

'

'

170,493

'

'

'

264,540

170,493

143,031

Depreciation and amortization

'

'

'

'

'

'

'

'

1,353

[2]

1,587

[2]

1,447

[2]

Total capital expenditures

'

'

'

'

'

'

'

'

2,635

2,191

3,423

Fluid & Metering Technologies

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

871,814

833,288

831,287

Operating income (loss)

'

'

'

'

'

'

'

'

211,256

[1]

146,650

[1]

164,818

[1]

Total assets

1,025,352

'

'

'

1,023,143

'

'

'

1,025,352

1,023,143

1,072,023

Depreciation and amortization

'

'

'

'

'

'

'

'

27,633

[2]

29,637

[2]

32,368

[2]

Total capital expenditures

'

'

'

'

'

'

'

'

11,581

13,535

12,543

Fluid & Metering Technologies | External Customers

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

870,720

829,320

830,821

Fluid & Metering Technologies | Intersegment Eliminations

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

1,094

3,968

466

Health & Science Technologies

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

714,650

695,235

607,900

Operating income (loss)

'

'

'

'

'

'

'

'

136,707

[1],[3]

-62,835

[1],[3]

106,037

[1],[3]

Total assets

1,113,546

'

'

'

1,102,868

'

'

'

1,113,546

1,102,868

1,178,653

Depreciation and amortization

'

'

'

'

'

'

'

'

43,496

[2]

39,981

[2]

30,055

[2]

Total capital expenditures

'

'

'

'

'

'

'

'

12,280

13,140

12,938

Health & Science Technologies | External Customers

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

708,940

689,574

606,247

Health & Science Technologies | Intersegment Eliminations

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

5,710

5,661

1,653

Fire & Safety/Diversified Products

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

445,049

437,053

402,425

Operating income (loss)

'

'

'

'

'

'

'

'

102,730

[1],[3]

96,120

[1],[3]

85,901

[1],[3]

Total assets

484,139

'

'

'

488,886

'

'

'

484,139

488,886

442,400

Depreciation and amortization

'

'

'

'

'

'

'

'

6,852

[2]

7,107

[2]

8,516

[2]

Total capital expenditures

'

'

'

'

'

'

'

'

5,040

6,654

5,644

Fire & Safety/Diversified Products | External Customers

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

444,470

435,364

401,383

Fire & Safety/Diversified Products | Intersegment Eliminations

'

'

'

'

'

'

'

'

'

'

'

Segment Reporting Information [Line Items]

'

'

'

'

'

'

'

'

'

'

'

Segment sales

'

'

'

'

'

'

'

'

$579

$1,689

$1,042

[1]

(1)Segment operating income excludes net unallocated corporate operating expenses.

[2]

Excludes amortization of debt issuance expenses.

[3]

(2)Segment operating income includes asset impairment charges in 2012 of $27.7 million within the FluidB & Metering Technologies segment and $170.8 million within the HealthB & Science Technologies segment.

Schedule_of_Information_on_Com1

Schedule of Information on Company's Business Segments (Parenthetical) (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]	'	'	'	'
Asset impairment charge	$198,500	$0	$198,519	$0
Fluid & Metering Technologies	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Asset impairment charge	'	27,700	'	'
Health & Science Technologies	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Asset impairment charge	'	$170,800	'	'

Schedule_of_Sales_from_Externa

Schedule of Sales from External Customers and Long Lived Assets (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Total net sales	$2,024,130	$1,954,258	$1,838,451
Total long-lived assets - net	213,488	219,161	213,717
U.S.	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Total net sales	983,791	963,137	857,990
Total long-lived assets - net	124,880	127,425	124,102
Europe	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Total net sales	521,491	479,744	492,125
Total long-lived assets - net	63,018	64,137	63,433
Asia [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Total net sales	306,466	305,185	278,900
Total long-lived assets - net	24,590	26,320	24,570
Other Countries	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Total net sales	212,382	206,192	209,436
Total long-lived assets - net	$1,000	$1,279	$1,612

Acquisitions_Additional_Inform

Acquisitions - Additional Information (Detail)

12 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2013

Mar. 18, 2013

Mar. 18, 2013

Apr. 11, 2012

Dec. 31, 2012

Apr. 30, 2012

Apr. 30, 2012

Dec. 31, 2012

Jul. 20, 2012

Jul. 20, 2012

Nov. 30, 2013

Dec. 31, 2012

Dec. 31, 2013

Jan. 31, 2011

Mar. 11, 2011

Jun. 10, 2011

Dec. 31, 2011

Dec. 31, 2011

Sep. 17, 2010

USD ($)

USD ($)

USD ($)

Cost of Sales [Member]

Trade Names

FTL

FTL

PPC

PPC

ERC

ERC

ERC

Matcon

Matcon

Matcon

Matcon

Matcon

At Films

Microfluidics

CVI MG

CVI MG

CVI MG

Periflo

USD ($)

USD ($)

GBP (£)

USD ($)

USD ($)

USD ($)

JPY (¥)

USD ($)

USD ($)

GBP (£)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Trade Names

USD ($)

USD ($)

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Annual revenue of entity acquired

'

'

'

'

'

$22,500,000

£ 15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate purchase price

'

'

'

'

'

'

'

'

'

18,000,000

1,470,000,000

'

45,800,000

29,100,000

'

'

'

34,500,000

'

394,700,000

'

'

'

Business combination, cash consideration paid

'

'

'

'

'

34,500,000

23,100,000

20,600,000

'

13,300,000

'

'

35,000,000

'

'

'

'

31,800,000

18,500,000

393,300,000

'

'

'

Goodwill

'

50,387,000

232,613,000

'

'

17,994,000

'

13,900,000

13,941,000

8,500,000

'

8,499,000

28,000,000

'

'

27,947,000

'

18,200,000

5,900,000

208,500,000

208,540,000

'

'

Acquisition cash payment made for funded from operation

'

'

'

'

'

'

'

20,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Goodwill not deductible for tax purpose

'

'

'

'

'

18,000,000

'

13,900,000

'

8,500,000

'

'

28,000,000

'

'

'

'

18,200,000

5,900,000

'

'

'

'

Business combination, working capital adjustments

'

'

'

'

'

'

'

'

'

'

'

'

2,400,000

'

'

'

'

'

'

'

'

'

'

Contingent consideration value as of opening balance sheet date

'

9,043,000

'

'

'

'

'

'

'

'

'

'

8,400,000

'

'

9,000,000

4,900,000

2,700,000

'

'

'

'

'

Business Combination, Contingent Consideration, Liability

'

9,043,000

'

'

'

'

'

'

'

'

'

'

8,400,000

'

'

9,000,000

4,900,000

2,700,000

'

'

'

'

'

Business combination, amount financed with borrowings under the revolving facility

'

'

'

'

'

'

'

'

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

Acquisition-related transaction costs

1,400,000

2,700,000

'

'

'

'

'

'

'

'

'

'

'

'

4,100,000

600,000

'

'

'

'

'

'

'

Fair value of inventory charges associated with acquisitions

1,800,000

'

'

900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Goodwill deductible for tax purpose

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,200,000

'

117,700,000

'

'

2,500,000

Purchase price financed with borrowings under revolving credit facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

365,000,000

'

'

'

Acquired intangible assets amortization life

'

'

'

'

'16 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'15 years

'

Acquisition related transaction costs

'

'

5,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Assumption of debt

'

'

'

'

'

'

'

'

'

4,700,000

'

'

'

'

'

'

'

'

'

1,400,000

'

'

'

Intangible assets

'

24,827,000

136,929,000

'

'

13,016,000

'

5,100,000

5,104,000

5,600,000

'

5,642,000

14,100,000

'

'

14,081,000

'

11,400,000

9,700,000

115,800,000

115,777,000

'

'

Intangible assets, finite-lived

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

47,000,000

'

Intangible assets, indefinite-lived

'

'

$89,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocation_of_Acquisition_Cost

Allocation of Acquisition Costs to Assets Acquired and Liabilities Assumed (Detail) (USD $)	Dec. 31, 2012	Dec. 31, 2011	Mar. 18, 2013	Dec. 31, 2012	Apr. 30, 2012	Dec. 31, 2012	Apr. 11, 2012	Dec. 31, 2012	Jul. 20, 2012	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2011	Jun. 10, 2011
In Thousands, unless otherwise specified			FTL	ERC	ERC	PPC	PPC	Matcon	Matcon	Advanced Thin Films, LLC	Microfluidics International Corporation	CVI MG	CVI MG
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'	'	'	'	'
Accounts receivable	$14,411	$26,685	$3,454	$5,766	'	$877	'	$7,768	'	$947	$1,760	$23,978	'
Inventory	5,760	55,946	4,524	4,224	'	932	'	604	'	852	2,226	52,868	'
Other current assets, net of cash acquired	3,113	8,451	131	981	'	252	'	1,880	'	73	816	7,562	'
Property, plant and equipment	10,369	36,635	1,357	2,738	'	1,936	'	5,695	'	5,019	567	31,049	'
Goodwill	50,387	232,613	17,994	8,499	8,500	13,941	13,900	27,947	28,000	18,220	5,853	208,540	208,500
Intangible assets	24,827	136,929	13,016	5,642	5,600	5,104	5,100	14,081	14,100	11,435	9,717	115,777	115,800
Other assets	1,575	5,391	'	1,509	'	13	'	53	'	2,731	548	2,112	'
Total assets acquired	110,442	502,650	40,476	29,359	'	23,055	'	58,028	'	39,277	21,487	441,886	'
Total liabilities assumed	-30,754	-56,289	-5,939	-16,074	'	-2,465	'	-12,215	'	-4,766	-2,951	-48,572	'
Net assets acquired	$79,688	$446,361	$34,537	$13,285	'	$20,590	'	$45,813	'	$34,511	$18,536	$393,314	'

Acquired_Intangible_Assets_and

Acquired Intangible Assets and Weighted Average Amortization Periods (Detail) (USD $)	0 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 18, 2013	Dec. 31, 2012	Dec. 31, 2011
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Intangible assets, Total	$13,016	$24,827	$89,921
Trade Names	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Intangible assets, Total	1,005	8,973	4,168
Weighted Average Life	'15 years	'15 years	'15 years
Non-Compete Agreements	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Intangible assets, Total	224	470	793
Weighted Average Life	'3 years	'3 years	'2 years
Customer Relationships	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Intangible assets, Total	10,950	11,343	53,895
Weighted Average Life	'9 years	'6 years	'7 years
Unpatented technology and other	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Intangible assets, Total	837	4,041	28,048
Weighted Average Life	'8 years	'8 years	'6 years
Patents	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'
Intangible assets, Total	'	'	$3,017
Weighted Average Life	'	'	'10 years

ShareBased_Compensation_Additi

Share-Based Compensation - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	share-based_compensation_plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of share-based compensation plans	2	'	'
Number of shares authorized	10,600,000	'	'
Number of shares available for future issuance	2,700,000	'	'
Stock option exercisable life	'10 years	'	'
Unvested shares, granted	200,000	200,000	300,000
Total intrinsic value of options exercised	$34,300,000	$23,500,000	$21,900,000
Cash received from options exercised	35,306,000	45,771,000	33,064,000
Tax benefit realized for the tax deductions from stock options exercised	12,500,000	8,600,000	8,000,000
Share-based compensation expense	16,993,000	13,102,000	12,076,000
Share based compensation, accrued expenses	2,000,000	2,000,000	'
Share based compensation, other noncurrent liabilities	1,000,000	'	'
Award requisite service period	'3 years	'	'
Non-Executive [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Share-based compensation expense	3,600,000	2,300,000	800,000
Non-Employee Directors Cliff	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting period of option	'1 year	'	'
Unvested Share And Unvested Share Unit Awards	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting period of option	'3 years	'	'
Performance Shares [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Unvested shares, granted	54,065	'	'
Total unrecognized compensation cost	1,800,000	'	'
Weighted-average period of total unrecognized compensation cost, in years	'1 year 1 month 6 days	'	'
Stock Option	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Total unrecognized compensation cost	9,100,000	'	'
Weighted-average period of total unrecognized compensation cost, in years	'1 year 3 months 18 days	'	'
Share-based compensation expense	6,268,000	6,292,000	6,958,000
Unvested Shares	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Unvested shares, granted	232,418	'	'
Total unrecognized compensation cost	12,300,000	'	'
Weighted-average period of total unrecognized compensation cost, in years	'1 year	'	'
Share-based compensation expense	$9,851,000	$6,810,000	$5,118,000
Minimum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Target award	0.00%	'	'
Maximum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Target award	200.00%	'	'
Target payout	100.00%	'	'

Schedule_of_Weighted_Average_O

Schedule of Weighted Average Option Fair Values and Assumptions (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'	'
Weighted average fair value of grants	$12.97	$11.40	$12.30
Dividend yield	1.57%	1.59%	1.46%
Volatility	30.92%	32.00%	32.72%
Risk-free interest rate, minimum	0.17%	0.17%	0.28%
Risk-free interest rate, maximum	4.12%	3.96%	5.61%
Expected life (in years)	'5 years 10 months 10 days	'5 years 11 months 23 days	'6 years 1 month 21 days

Schedule_of_Weighted_Average_P

Schedule of Weighted Average Performance Share Units Fair Values and Assumptions (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Weighted average fair value of grants	$12.97	$11.40	$12.30
Dividend yield	1.57%	1.59%	1.46%
Volatility	30.92%	32.00%	32.72%
Expected life (in years)	'5 years 10 months 10 days	'5 years 11 months 23 days	'6 years 1 month 21 days
Performance Shares [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Weighted average fair value of grants	$59.58	'	'
Dividend yield	0.00%	'	'
Volatility	28.99%	'	'
Risk-free interest rate	0.40%	'	'
Expected life (in years)	'2 years 10 months 13 days	'	'

Schedule_of_Compensation_Cost_

Schedule of Compensation Cost for Stock Options and Unvested Shares (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	$16,993	$13,102	$12,076
Stock Option	'	'	'
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	6,268	6,292	6,958
Income tax benefit	-2,016	-1,988	-2,208
Total expense after income taxes	4,252	4,304	4,750
Stock Option | Cost Of Goods Sold	'	'	'
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	479	650	805
Stock Option | Selling, General And Administrative Expenses	'	'	'
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	5,789	5,642	6,153
Unvested Shares	'	'	'
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	9,851	6,810	5,118
Income tax benefit	-2,296	-1,682	-1,827
Total expense after income taxes	7,555	5,128	3,291
Unvested Shares | Cost Of Goods Sold	'	'	'
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	1,380	991	684
Unvested Shares | Selling, General And Administrative Expenses	'	'	'
Compensation Related Costs Share Based Payments Disclosure [Line Items]	'	'	'
Total expense before income taxes	$8,471	$5,819	$4,434

Compensation_Cost_for_Performa

Compensation Cost for Performance Share Units (Details) (Performance Shares [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'
Total expense before income taxes	$873
Income tax benefit	-280
Total expense after income taxes	593
Cost of Sales [Member]	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'
Total expense before income taxes	0
Selling, General And Administrative Expenses	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'
Total expense before income taxes	$873

Stock_Options_Activity_Detail

Stock Options Activity (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Shares	'	'
Outstanding at January 1, 2012	3,223,742	'
Granted	651,022	'
Exercised	-1,245,817	'
Forfeited/Expired	-112,329	'
Outstanding at December 31, 2012	2,516,618	3,223,742
Vested and expected to vest at December 31, 2012	2,400,548	'
Exercisable at December 31, 2012	1,086,636	'
Weighted Average Price	'	'
Stock Options Outstanding, Weighted Average Price, Beginning	$33.16	'
Granted, Weighted Average Price	$50.70	'
Exercised, Weighted Average Price	$28.41	'
Forfeited/Expired, Weighted Average Price	$43.23	'
Stock Options Outstanding, Weighted Average Price, Ending	$39.60	$33.16
Vested and expected to vest at December 31, 2012, Weighted Average Price	$39.23	'
Exercisable at December 31, 2012, Weighted Average Price	$32.47	'
Weighted-Average Remaining Contractual Term	'	'
Weighted-Average Remaining Contractual Term	'6 years 10 months 13 days	'6 years 4 months 13 days
Vested and expected to vest at December 31, 2012, Weighted-Average Remaining Contractual Term	'6 years 9 months 11 days	'
Exercisable, Weighted-Average Remaining Contractual Term	'5 years 0 months 18 days	'
Aggregate Intrinsic Value	'	'
Stock options outstanding, Beginning aggregate intrinsic value	$43,106,153	'
Stock options outstanding, Ending aggregate intrinsic value	86,200,655	43,106,153
Stock options, vested and expected to vest aggregate intrinsic value	83,095,331	'
Stock options, exercisable aggregate intrinsic value	$44,963,329	'

Unvested_Share_Activity_Detail

Unvested Share Activity (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Shares	'	'	'
Granted, Shares	200,000	200,000	300,000
Weighted-Average Grant Date Fair Value	'	'	'
Nonvested, Weighted-Average Grant Date Fair Value, Beginning Balance	$40.27	'	'
Granted, Weighted-Average Grant Date Fair Value	$56.20	'	'
Vested, Weighted-Average Grant Date Fair Value	$38.50	'	'
Forfeited, Weighted-Average Grant Date Fair Value	$53.58	'	'
Nonvested, Weighted-Average Grant Date Fair Value, Ending Balance	$40.27	$40.27	'
Unvested Shares	'	'	'
Shares	'	'	'
Nonvested, Beginning Balance	589,986	'	'
Granted, Shares	232,418	'	'
Vested, Shares	-154,795	'	'
Forfeited, Shares	-48,930	'	'
Nonvested, Ending Balance	618,679	'	'

Performance_Share_Unit_Activit

Performance Share Unit Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Shares	'	'	'
Granted, Shares	200,000	200,000	300,000
Weighted-Average Grant Date Fair Value	'	'	'
Nonvested, Weighted-Average Grant Date Fair Value, Beginning Balance	$40.27	'	'
Granted, Weighted-Average Grant Date Fair Value	$56.20	'	'
Vested, Weighted-Average Grant Date Fair Value	$38.50	'	'
Forfeited, Weighted-Average Grant Date Fair Value	$53.58	'	'
Nonvested, Weighted-Average Grant Date Fair Value, Ending Balance	$40.27	$40.27	'
Performance Shares [Member]	'	'	'
Shares	'	'	'
Nonvested, Beginning Balance	0	'	'
Granted, Shares	54,065	'	'
Vested, Shares	0	'	'
Forfeited, Shares	-860	'	'
Nonvested, Ending Balance	53,205	'	'
Weighted-Average Grant Date Fair Value	'	'	'
Nonvested, Weighted-Average Grant Date Fair Value, Beginning Balance	$0	'	'
Granted, Weighted-Average Grant Date Fair Value	$59.58	'	'
Vested, Weighted-Average Grant Date Fair Value	$0	'	'
Forfeited, Weighted-Average Grant Date Fair Value	$59.58	'	'
Nonvested, Weighted-Average Grant Date Fair Value, Ending Balance	$59.58	'	'

Other_Comprehensive_Income_Los2

Other Comprehensive Income (Loss) (Components of Other Comprehensive Income (Loss)) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity [Abstract]	'	'	'
Cumulative translation adjustment, Pre-tax	$13,572	$14,445	($14,108)
Cumulative translation adjustment, Tax	0	0	0
Cumulative translation adjustment, Net of Tax	13,572	14,445	-14,108
Pension and Other Postretirement Adjustments	'	'	'
Net gain (loss) arising during the year, Pre-tax	26,274	-16,607	-18,066
Net gain (loss) arising during the year, Tax	-9,859	3,107	6,038
Net gain (loss) arising during the year, Net of Tax	16,415	-13,500	-12,028
Amortization/settlement recognition of net loss (gain), Pre-tax	8,599	7,801	5,446
Amortization/settlement recognition of net loss (gain), Tax	-3,226	-1,460	-1,816
Amortization/settlement recognition of net loss (gain), Net of Tax	5,373	6,341	3,630
Pension and other postretirement adjustments, Pre-tax	34,873	-8,806	-12,620
Pension and other postretirement adjustments, Tax	-13,085	1,647	4,222
Pension and other postretirement adjustments, Net of Tax	21,788	-7,159	-8,398
Reclassification adjustments for derivatives, Pre-tax	7,430	7,571	-32,754
Reclassification adjustments for derivatives, Tax	-2,692	-2,791	12,500
Reclassification adjustments for derivatives, Net of tax	4,738	4,780	-20,254
Total other comprehensive income (loss), Pre-tax	55,875	13,210	-59,482
Total other comprehensive income (loss), Tax	-15,777	-1,144	16,722
Total other comprehensive income (loss), Net of Tax	$40,098	$12,066	($42,760)

Other_Comprehensive_Income_Los3

Other Comprehensive Income (Loss) (Amounts Reclassified from Accumulated Other Comprehensive Income (Loss)) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Selling, general and administrative expenses	$477,851	$444,490	$421,703
Interest expense	42,206	42,250	29,332
Provision for income taxes	-97,914	-48,574	-80,024
Reclassification out of Accumulated Other Comprehensive Income [Member] | Pension and Other Postretirement Plans [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Selling, general and administrative expenses	8,599	7,801	5,446
Total before tax	8,599	7,801	5,446
Provision for income taxes	-3,226	-1,460	-1,816
Total net of tax	5,373	6,341	3,630
Reclassification out of Accumulated Other Comprehensive Income [Member] | Derivatives [Member]	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'
Interest expense	7,430	7,571	-32,754
Total before tax	7,430	7,571	-32,754
Provision for income taxes	-2,692	-2,791	12,500
Total net of tax	$4,738	$4,780	($20,254)

Reconciliation_Of_Changes_In_B

Reconciliation Of Changes In Benefit Obligations And Fair Value Of Plan Assets (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CHANGE IN BENEFIT OBLIGATION	'	'	'
Obligation at December 31	'	$25,587	'
CHANGE IN PLAN ASSETS	'	'	'
Fair value of plan assets at December 31	104,291	94,238	'
Other noncurrent liabilities	-67,777	-96,853	'
Pension Plans | U S Plans	'	'	'
CHANGE IN BENEFIT OBLIGATION	'	'	'
Obligation at January 1	111,188	101,511	'
Service cost	1,526	1,756	'
Interest cost	3,766	4,247	'
Plan amendments	0	59	'
Benefits paid	-2,479	-4,097	'
Actuarial loss (gain)	-11,885	13,202	'
Currency translation	0	0	'
Curtailments/settlements	-9,277	-5,490	'
Acquisition	0	0	'
Obligation at December 31	92,839	111,188	'
CHANGE IN PLAN ASSETS	'	'	'
Fair value of plan assets at January 1	74,578	59,619	'
Actual return on plan assets	14,303	6,177	'
Employer contributions	4,832	17,287	'
Currency translation	0	0	'
Settlements	-9,277	-4,408	'
Other	0	0	'
Fair value of plan assets at December 31	81,957	74,578	'
Funded status at December 31	-10,882	-36,610	'
Current liabilities	-656	-588	'
Other noncurrent liabilities	-10,226	-36,022	'
Net liability at December 31	-10,882	-36,610	'
Pension Plans | U S Plans | Defined Benefit Plan Benefit Obligations	'	'	'
CHANGE IN BENEFIT OBLIGATION	'	'	'
Benefits paid	-2,479	-4,097	'
Pension Plans | Non U S Plans	'	'	'
CHANGE IN BENEFIT OBLIGATION	'	'	'
Obligation at January 1	56,555	47,763	'
Service cost	1,388	1,300	'
Interest cost	2,146	2,206	'
Plan amendments	0	410	'
Benefits paid	-1,957	-3,536	'
Actuarial loss (gain)	581	6,700	'
Currency translation	1,758	1,712	'
Curtailments/settlements	0	0	'
Acquisition	0	0	'
Obligation at December 31	60,471	56,555	'
CHANGE IN PLAN ASSETS	'	'	'
Fair value of plan assets at January 1	19,660	16,914	'
Actual return on plan assets	2,341	1,944	'
Employer contributions	1,840	3,514	'
Currency translation	447	810	'
Settlements	3	0	'
Other	0	14	'
Fair value of plan assets at December 31	22,334	19,660	'
Funded status at December 31	-38,138	-36,894	'
Current liabilities	-995	-743	'
Other noncurrent liabilities	-37,143	-36,151	'
Net liability at December 31	-38,138	-36,894	'
Pension Plans | Non U S Plans | Defined Benefit Plan Benefit Obligations	'	'	'
CHANGE IN BENEFIT OBLIGATION	'	'	'
Benefits paid	-1,957	-3,536	'
Other Postretirement Benefit Plans	'	'	'
CHANGE IN BENEFIT OBLIGATION	'	'	'
Obligation at January 1	25,587	21,073	'
Service cost	968	763	691
Interest cost	906	922	1,035
Plan amendments	0	159	'
Benefits paid	-801	-704	'
Actuarial loss (gain)	-5,139	3,313	'
Currency translation	-167	61	'
Curtailments/settlements	0	0	'
Acquisition	0	0	'
Obligation at December 31	21,354	25,587	21,073
CHANGE IN PLAN ASSETS	'	'	'
Fair value of plan assets at January 1	0	0	'
Actual return on plan assets	0	0	'
Employer contributions	801	704	'
Currency translation	0	0	'
Settlements	0	0	'
Other	0	0	'
Fair value of plan assets at December 31	0	0	0
Funded status at December 31	-21,354	-25,587	'
Current liabilities	-946	-907	'
Other noncurrent liabilities	-20,408	-24,680	'
Net liability at December 31	-21,354	-25,587	'
Other Postretirement Benefit Plans | Defined Benefit Plan Benefit Obligations	'	'	'
CHANGE IN BENEFIT OBLIGATION	'	'	'
Benefits paid	($801)	($704)	'

Reconciliation_Of_Changes_In_B1

Reconciliation Of Changes In Benefit Obligations And Fair Value Of Plan Assets (Parenthetical) (Detail) (Pension Plans, U S Plans, USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Pension Plans | U S Plans	'
Defined Benefit Plan Disclosure [Line Items]	'
Employer contributions, discretionary contribution	$10

Retirement_Benefits_Additional

Retirement Benefits - Additional Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	employee
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Accumulated benefit obligation for all defined benefit pension plans	$143.50	$160.70	'
Percentage of excess gains and losses over benefit obligation or market value of assets amortized	10.00%	'	'
Costs of defined contribution plans	8.4	7.9	7.8
Number of participants covering under multi employer pension plan	393	'	'
Costs of bargaining unit-sponsored multi-employer plans and defined contribution plans	1.1	1	1
Weighted average annual rate of increase in the per capita cost of covered health care benefits assumed	7.27%	'	'
Assumed decrease of weighted average health care cost trend rate	4.49%	'	'
Year that reaches assumed decrease of weighted average health care cost trend rate	'2027	'	'
Increase in service and interest cost components of the net periodic benefit cost, as 1% increase in health care cost trend rates	0.2	'	'
Increase in accumulated postretirement benefit obligation, as 1% increase in health care cost trend rates	1.4	'	'
Decrease in service and interest cost components of the net periodic benefit cost, as 1% decrease in health care cost trend rates	0.2	'	'
Decrease in accumulated postretirement benefit obligation, as 1% decrease in health care cost trend rates	1.2	'	'
Minimum fund performance period of plan assets	'3 years	'	'
Maximum fund performance period of plan assets	'5 years	'	'
Future estimated benefit payments for year 2013	9.1	'	'
Future estimated benefit payments for year 2014	8.5	'	'
Future estimated benefit payments for year 2015	9	'	'
Future estimated benefit payments for year 2016	9.4	'	'
Future estimated benefit payments for year 2017	9.9	'	'
Future estimated benefit payments for years 2018 to 2022	53	'	'
Pension Plans	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Expected contribution for next fiscal year	2.8	'	'
Other Postretirement Benefit Plans	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Expected contribution for next fiscal year	0.9	'	'
Defined Contribution Plan	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Expected contribution for next fiscal year	8.4	'	'
Defined Contribution Pension Plan 401k	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Expected contribution for next fiscal year	$7.30	'	'
Equity Securities	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Target allocation of fund assets in equities, minimum	50.00%	'	'
Target allocation of fund assets in equities, maximum	60.00%	'	'
Target allocation of fund assets in equities	50.00%	'	'
Debt Securities	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Target allocation of fund assets in equities, minimum	40.00%	'	'
Target allocation of fund assets in equities, maximum	50.00%	'	'
Target allocation of fund assets in equities	50.00%	'	'

Weighted_Average_Assumptions_U

Weighted Average Assumptions Used in the Measurement Of Benefit Obligation (Detail)	Dec. 31, 2013	Dec. 31, 2012
U S Plans	'	'
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]	'	'
Discount rate	4.61%	3.56%
Rate of compensation increase	4.00%	3.94%
Non U S Plans	'	'
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]	'	'
Discount rate	4.03%	3.91%
Rate of compensation increase	3.14%	2.99%

Pretax_Amounts_Recognized_in_A

Pretax Amounts Recognized in Accumulated Other Comprehensive Income Loss (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
U S Plans	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Net loss in current year	$20,869	'
Prior service cost	0	'
Amortization of prior service cost (credit)	104	'
Amortization of net loss	7,518	'
Exchange rate effect on amounts in OCI	0	'
Total	28,491	'
Non U S Plans	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Net loss in current year	708	'
Prior service cost	0	'
Amortization of prior service cost (credit)	25	'
Amortization of net loss	929	'
Exchange rate effect on amounts in OCI	-410	'
Total	1,252	'
Pension Plans | U S Plans	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Prior service cost (credit)	170	275
Net loss	22,854	51,240
Total	23,024	51,515
Pension Plans | Non U S Plans	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Prior service cost (credit)	312	330
Net loss	14,262	15,496
Total	14,574	15,826
Other Postretirement Benefit Plans	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Prior service cost (credit)	-1,951	-2,325
Net loss	-225	5,279
Total	-2,176	2,954
Net loss in current year	5,140	'
Prior service cost	0	'
Amortization of prior service cost (credit)	-373	'
Amortization of net loss	396	'
Exchange rate effect on amounts in OCI	-33	'
Total	$5,130	'

Amounts_in_Accumulated_Other_C

Amounts in Accumulated Other Comprehensive Income Loss Expected to be Recognized As Components of Net Periodic Benefit Cost During 2012 (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
Prior service cost (credit)	($261)
Net loss	3,052
Total	2,791
Pension Plans | U S Plans	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
Prior service cost (credit)	84
Net loss	2,306
Total	2,390
Pension Plans | Non U S Plans	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
Prior service cost (credit)	26
Net loss	851
Total	877
Other Postretirement Benefit Plans	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
Prior service cost (credit)	-371
Net loss	-105
Total	($476)

Components_of_Net_Periodic_Ben

Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
U.S.	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Service cost	$1,526	$1,756	$1,759
Interest cost	3,766	4,247	4,506
Expected return on plan assets	-5,318	-4,687	-4,755
Net amortization	7,621	5,376	4,855
Net periodic benefit cost	7,595	6,692	6,365
Non-U.S.	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Service cost	1,388	1,300	1,078
Interest cost	2,146	2,206	2,320
Expected return on plan assets	-1,055	-1,035	-1,117
Net amortization	955	589	442
Net periodic benefit cost	3,434	3,060	2,723
Other Postretirement Benefit Plans	'	'	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'	'	'
Service cost	968	763	691
Interest cost	906	922	1,035
Net amortization	24	11	-156
Net periodic benefit cost	$1,898	$1,696	$1,570

Weighted_Average_Assumptions_U1

Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost of Plans (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
U S Plans	'	'	'
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]	'	'	'
Discount rate	3.56%	4.45%	5.20%
Expected return on plan assets	7.50%	8.00%	8.25%
Rate of compensation increase	3.94%	3.90%	3.90%
Non U S Plans	'	'	'
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]	'	'	'
Discount rate	3.91%	4.68%	5.35%
Expected return on plan assets	5.53%	5.90%	6.17%
Rate of compensation increase	2.99%	2.96%	3.37%

Pension_Plan_Weighted_Average_

Pension Plan Weighted Average Asset Allocations (Detail)	Dec. 31, 2013	Dec. 31, 2012
Schedule of Defined Benefit Plan Asset Allocation Targets [Line Items]	'	'
Defined Benefit Plan Securities	100.00%	100.00%
Equity Securities	'	'
Schedule of Defined Benefit Plan Asset Allocation Targets [Line Items]	'	'
Defined Benefit Plan Securities	66.00%	68.00%
Debt Securities	'	'
Schedule of Defined Benefit Plan Asset Allocation Targets [Line Items]	'	'
Defined Benefit Plan Securities	34.00%	32.00%

Summary_of_Basis_Used_to_Measu

Summary of Basis Used to Measure Defined Benefit Plans Assets at Fair Value (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	$104,291	$94,238
U.S. Large Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	31,831	32,496
U.S. Small / Mid Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	8,783	7,770
International, Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	25,591	20,869
U.S. Intermediate [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	18,715	25,069
U.S. Short Duration [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	8,954	0
U.S. High Yield [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	1,581	0
International, Fixed Income [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	5,812	5,489
Insurance Contracts [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	331	326
Cash and Cash Equivalents [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	2,693	2,219
Level 1	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	103,960	86,451
Level 1 | U.S. Large Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	31,831	32,496
Level 1 | U.S. Small / Mid Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	8,783	7,770
Level 1 | International, Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	25,591	13,082
Level 1 | U.S. Intermediate [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	18,715	25,069
Level 1 | U.S. Short Duration [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	8,954	0
Level 1 | U.S. High Yield [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	1,581	0
Level 1 | International, Fixed Income [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	5,812	5,489
Level 1 | Insurance Contracts [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	326
Level 1 | Cash and Cash Equivalents [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	2,693	2,219
Level 2	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	331	7,787
Level 2 | U.S. Large Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 2 | U.S. Small / Mid Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 2 | International, Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	7,787
Level 2 | U.S. Intermediate [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 2 | U.S. Short Duration [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 2 | U.S. High Yield [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 2 | International, Fixed Income [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 2 | Insurance Contracts [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	331	0
Level 2 | Cash and Cash Equivalents [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | U.S. Large Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | U.S. Small / Mid Cap [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | International, Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | U.S. Intermediate [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | U.S. Short Duration [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | U.S. High Yield [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | International, Fixed Income [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | Insurance Contracts [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	0	0
Level 3 | Cash and Cash Equivalents [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Defined benefit plan, fair value of plan assets	$0	$0

Unaudited_Quarterly_Results_of

Unaudited Quarterly Results of Operations (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Quarterly Financial Information Disclosure [Abstract]	'	'	'	'	'	'	'	'	'		'		'
Net sales	$520,620	$490,617	$518,445	$494,448	$490,838	$479,859	$494,144	$489,417	$2,024,130		$1,954,258		$1,838,451
Gross profit	227,009	211,509	222,849	211,997	202,858	194,840	203,113	202,889	873,364		803,700		738,673
Operating income (loss)	103,873	97,369	99,559	94,712	-125,589	80,588	88,650	84,569	395,513	[1]	128,218	[1]	304,656	[1]
Net income (loss)	$67,555	$63,799	$62,561	$61,300	($119,019)	$50,127	$54,351	$52,171	$255,215		$37,630		$193,857
Basic EPS	$0.83	$0.78	$0.76	$0.74	($1.45)	$0.60	$0.65	$0.63	$3.11		$0.45		$2.34
Diluted EPS	$0.82	$0.78	$0.76	$0.74	($1.45)	$0.60	$0.65	$0.62	$3.09		$0.45		$2.32
Basic weighted average shares outstanding	80,782	81,259	81,829	82,197	82,296	82,482	83,180	82,804	81,517		82,689		82,145
Diluted weighted average shares outstanding	81,854	82,218	82,734	83,152	82,296	83,370	84,090	83,902	82,489		83,641		83,543
[1]	(1)Segment operating income excludes net unallocated corporate operating expenses.

Unaudited_Quarterly_Results_of1

Unaudited Quarterly Results of Operations (Parenthetical) (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Financial Information Disclosure [Abstract]	'	'	'	'
Asset impairment charge	$198,500	$0	$198,519	$0